Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	Ceramidse_alk_C	ASAH2 ASAH2B	5.11e-05	2	134	2	PF17048
Domain	NEUT/ALK_ceramidase_C	ASAH2 ASAH2B	5.11e-05	2	134	2	IPR031331
Domain	Ceramidase_alk	ASAH2 ASAH2B	5.11e-05	2	134	2	IPR006823
Domain	BRK	CHD9 CHD6	7.52e-04	6	134	2	SM00592
Domain	BRK_domain	CHD9 CHD6	7.52e-04	6	134	2	IPR006576
Domain	TNF_rcpt--assoc_TRAF	TRAF3 TRAF5	7.52e-04	6	134	2	IPR012227
Domain	BRK	CHD9 CHD6	7.52e-04	6	134	2	PF07533
Domain	DEATH	ANK2 DAPK1 NGFR	9.31e-04	27	134	3	SM00005
Domain	RhoGAP	ARHGAP17 OCRL ARHGAP29 ARHGAP20	1.02e-03	62	134	4	SM00324
Domain	Helicase_C	TTF2 CHD9 FANCM DDX1 CHD6	1.04e-03	107	134	5	PF00271
Domain	HELICc	TTF2 CHD9 FANCM DDX1 CHD6	1.04e-03	107	134	5	SM00490
Domain	RhoGAP	ARHGAP17 OCRL ARHGAP29 ARHGAP20	1.09e-03	63	134	4	PF00620
Domain	Helicase_C	TTF2 CHD9 FANCM DDX1 CHD6	1.09e-03	108	134	5	IPR001650
Domain	HELICASE_CTER	TTF2 CHD9 FANCM DDX1 CHD6	1.13e-03	109	134	5	PS51194
Domain	HELICASE_ATP_BIND_1	TTF2 CHD9 FANCM DDX1 CHD6	1.13e-03	109	134	5	PS51192
Domain	DEXDc	TTF2 CHD9 FANCM DDX1 CHD6	1.13e-03	109	134	5	SM00487
Domain	RhoGAP_dom	ARHGAP17 OCRL ARHGAP29 ARHGAP20	1.15e-03	64	134	4	IPR000198
Domain	RHOGAP	ARHGAP17 OCRL ARHGAP29 ARHGAP20	1.15e-03	64	134	4	PS50238
Domain	-	ARHGAP17 OCRL ARHGAP29 ARHGAP20	1.15e-03	64	134	4	1.10.555.10
Domain	Helicase_ATP-bd	TTF2 CHD9 FANCM DDX1 CHD6	1.18e-03	110	134	5	IPR014001
Domain	zf-TRAF	TRAF3 TRAF5	1.39e-03	8	134	2	PF02176
Domain	SNF2_N	TTF2 CHD9 CHD6	1.54e-03	32	134	3	IPR000330
Domain	SNF2_N	TTF2 CHD9 CHD6	1.54e-03	32	134	3	PF00176
Domain	Death	ANK2 DAPK1 NGFR	1.68e-03	33	134	3	PF00531
Domain	DNA/RNA_helicase_DEAH_CS	TTF2 FANCM CHD6	2.00e-03	35	134	3	IPR002464
Domain	Death_domain	ANK2 DAPK1 NGFR	2.54e-03	38	134	3	IPR000488
Domain	DEAH_ATP_HELICASE	TTF2 FANCM CHD6	2.54e-03	38	134	3	PS00690
Domain	DEATH_DOMAIN	ANK2 DAPK1 NGFR	2.54e-03	38	134	3	PS50017
Domain	MATH	TRAF3 TRAF5	3.22e-03	12	134	2	PS50144
Domain	Znf_TRAF	TRAF3 TRAF5	3.22e-03	12	134	2	IPR001293
Domain	MATH/TRAF_dom	TRAF3 TRAF5	3.22e-03	12	134	2	IPR002083
Domain	MATH	TRAF3 TRAF5	3.22e-03	12	134	2	SM00061
Domain	MATH	TRAF3 TRAF5	3.22e-03	12	134	2	PF00917
Domain	DUF4599	SPATA31D4 SPATA31D3	3.22e-03	12	134	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	3.22e-03	12	134	2	IPR027970
Domain	Rho_GTPase_activation_prot	ARHGAP17 OCRL ARHGAP29 ARHGAP20	3.71e-03	88	134	4	IPR008936
Domain	ZF_TRAF	TRAF3 TRAF5	3.78e-03	13	134	2	PS50145
Domain	NHL	TRIM2 TENM4	3.78e-03	13	134	2	PS51125
Domain	UBA	RSC1A1 LATS1 UBAP2L	3.86e-03	44	134	3	IPR015940
Domain	-	TRAF3 TRAF5	4.39e-03	14	134	2	3.90.890.10
Domain	-	TRAF3 TRAF5	4.39e-03	14	134	2	2.60.210.10
Domain	UBA	RSC1A1 LATS1 UBAP2L	4.65e-03	47	134	3	PS50030
Domain	Kinase-like_dom	BMP2K NTRK3 DAPK1 CHD9 PTPN13 LATS1 DST CSNK1G2 DCLK2 PLK1	5.74e-03	542	134	10	IPR011009
Domain	SIAH-type	TRAF3 TRAF5	5.74e-03	16	134	2	IPR013323
Domain	HSP70	HSPA6 HSPA7	5.74e-03	16	134	2	PF00012
Domain	HSP70_2	HSPA6 HSPA7	6.48e-03	17	134	2	PS00329
Domain	HSP70_1	HSPA6 HSPA7	6.48e-03	17	134	2	PS00297
Domain	HSP70_3	HSPA6 HSPA7	6.48e-03	17	134	2	PS01036
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	EHBP1 TET2 NRIP1 ZNF536 TNRC6B ANKHD1 LUZP1 TOX4 PTPN13 DST RESF1 ALMS1 ZNF608 BRCA2 ZBTB10 CHD6 HSPA6 ZMYM4 PCNT	4.59e-15	418	136	19	34709266
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TTF2 IFT22 WASHC2C BMP2K TNRC6B OCRL TFCP2 LUZP1 CCDC66 LATS1 SMG7 ALMS1 BRCA2 MEIOC BTF3 COMMD2 CGN ARHGAP29 MINDY4 PLK1 PCNT	2.06e-11	853	136	21	28718761
Pubmed	Human transcription factor protein interaction networks.	NUSAP1 TET2 FLG ZNF536 TRAF3 TNRC6B DIDO1 ANKHD1 TFCP2 DDX1 FHAD1 DST RESF1 RNF2 SMG7 ALMS1 ZNF608 ATXN1 UBAP2L KLF5 MKI67 ZBTB10 CHD6 TRMT1L ZNF107 ZMYM4	5.34e-11	1429	136	26	35140242
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TTF2 TNRC6B DIDO1 ANKHD1 LUZP1 TOX4 PTPN13 LATS1 RNF2 SMG7 ALMS1 UBAP2L ANLN CGN PLK1 HSPA6 ZMYM4	6.00e-11	549	136	17	38280479
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ZFP90 ANKHD1 PLEKHM1 SPATA31D4 SPATA31D3 DST RESF1 ALMS1 UBAP2L NFE2L2 PDE4DIP MKI67	1.50e-10	233	136	12	37704626
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 TTF2 WASHC2C ANK2 TNRC6B DIDO1 OCRL ANKHD1 TFCP2 DNTTIP2 USP8 TOX4 PTPN13 DST SMG7 ALMS1 UBAP2L BTF3 MKI67 PCNT	7.34e-10	934	136	20	33916271
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 TET2 EXPH5 NTRK3 ARHGAP17 DDX1 LUZP1 USP8 PTPN13 LATS1 DST RESF1 ALMS1 ATXN1 ANLN CGN AKAP13 DCLK2 PLK1	1.24e-09	861	136	19	36931259
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	TTF2 BMP2K TNRC6B OCRL ANKHD1 SMG7 ALMS1 MEIOC UBAP2L CPEB4 PLK1	6.30e-08	322	136	11	39098523
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EHBP1 NRIP1 MAN1C1 AFF3 TNRC6B CHD9 PLEKHM1 PTPN13 SMG7 ZNF608 PTPRJ ATXN1 UBAP2L LOXL2 AKAP13 DCLK2 CHD6 ZNF107 MAML3 ZMYM4 PCNT SOS2	8.02e-08	1489	136	22	28611215
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	BMP2K TAF1C TNRC6B OCRL ANKHD1 TFCP2 LUZP1 PTPN13 RNF2 SMG7 UBAP2L BTF3 CPEB4 MKI67 AKAP13	1.75e-07	724	136	15	36232890
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TET2 ZFP90 DIDO1 ANKHD1 FRMD4B MYEF2 DST SMG7 ZNF608 PCNX1 IFT80 ARHGAP20 ZMYM4	1.78e-07	529	136	13	14621295
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	WASHC2C TNRC6B TFCP2 DNTTIP2 LUZP1 RESF1 ZNF608 BRCA2 UBAP2L ANLN HSPA6 ZMYM4	1.97e-07	444	136	12	34795231
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNRC6B TENM4 DST SMG7 ALMS1 ZNF608 PCNX1 CHD6 PCNT	2.78e-07	225	136	9	12168954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF536 WASHC2C TNRC6B SNX19 FOCAD USP8 TENM4 UBAP2L PDE4DIP CHD6 PCNT	6.49e-07	407	136	11	12693553
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	TET2 NRIP1 ANK2 TAF1C CHD9 ZNF302 REV3L FRMD4B FOCAD USP8 PTPN13 DST NFE2L2 PDE4DIP DCLK2 CHD6 ZMYM4 PCNT SOS2	6.70e-07	1285	136	19	35914814
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 EXPH5 TNRC6B PTPN13 SMG7 ALMS1 MEIOC CPEB4 MKI67	1.02e-06	263	136	9	34702444
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TTF2 TNRC6B LUZP1 USP8 PTPN13 LATS1 DST ALMS1 CGN CPEB4 PLK1	1.58e-06	446	136	11	24255178
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ARHGAP17 DIDO1 ANKHD1 LUZP1 SNCAIP DST ANLN BTF3 CGN PCNT	1.67e-06	360	136	10	33111431
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF536 TAF1C TNRC6B CHD9 REV3L ANKHD1 MYEF2 DNTTIP2 LUZP1 RESF1 HMCN2 SMG7 ALMS1 ZNF608 ATXN1 CPEB4 ZBTB10	1.83e-06	1116	136	17	31753913
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TET2 TNRC6B RESF1 ALMS1 ZNF608 BRCA2 PLK1	2.42e-06	152	136	7	38360978
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	NRIP1 COL6A3 ANK2 ZNF302 DNTTIP2 DST RNF2 ALMS1 ATXN1 PDE4DIP ZMYM4	4.45e-06	497	136	11	23414517
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	TNRC6B SNX19 LUZP1 PTPN13 CCDC66 SMG7 PLK1	4.87e-06	169	136	7	31462741
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	NRIP1 WASHC2C TNRC6B ANKHD1 ZNF804A TFCP2 TOX4 ATXN1 UBAP2L PDE4DIP LTBP1 CHD6	5.19e-06	608	136	12	16713569
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NUSAP1 BMP2K TAF1C TNRC6B DIDO1 ANKHD1 MYEF2 LUZP1 PTPN13 DST RNF2 ANLN CSNK1G2 BTF3 ISG20L2 CHD6 TRMT1L HSPA6 ZMYM4	6.21e-06	1497	136	19	31527615
Pubmed	TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction.	TRAF3 TRAF5 NGFR	6.88e-06	10	136	3	10514511
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NRIP1 TNRC6B SMG7 ALMS1 ATXN1 MKI67 ARHGAP29	8.50e-06	184	136	7	32908313
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	NUSAP1 TNRC6B LUZP1 CCDC66 DST ALMS1 ZNF608 UBAP2L ANLN LTBP1 CHD6 PCNT	9.38e-06	645	136	12	25281560
Pubmed	Temporally restricted death and the role of p75NTR as a survival receptor in the developing sensory nervous system.	NTRK3 MKI67 NGFR	9.43e-06	11	136	3	29569362
Pubmed	Evaluation of candidate markers for the peritubular myoid cell lineage in the developing mouse testis.	INHBA NTRK3 NGFR	9.43e-06	11	136	3	16183868
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	NUSAP1 EHBP1 BMP2K TNRC6B OCRL TFCP2 DNTTIP2 DDX1 LUZP1 PTPN13 LATS1 BTF3 PLK1 GNS ZMYM4	1.01e-05	1007	136	15	34597346
Pubmed	SUMOylation activates large tumour suppressor 1 to maintain the tissue homeostasis during Hippo signalling.	LATS1 BRCA2 MKI67	1.25e-05	12	136	3	34267330
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TET2 DST RESF1 ALMS1 UBAP2L IFT80	1.28e-05	130	136	6	12421765
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NUSAP1 TTF2 TAF1C DIDO1 FANCM TFCP2 DNTTIP2 TOX4 DST RNF2 NFE2L2 KLF5 MKI67 ISG20L2 CHD6 HSPA6 ZMYM4	1.28e-05	1294	136	17	30804502
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	ARHGAP29 AKAP13 ARHGEF3 SOS2	1.49e-05	38	136	4	19911011
Pubmed	ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2.	DDX1 TOX4 UBAP2L ZBTB10	1.49e-05	38	136	4	30629181
Pubmed	Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis.	NGFR AKAP13 ARHGEF3 SOS2	1.49e-05	38	136	4	11756498
Pubmed	Genomic structure and promoter analysis of the mouse neutral ceramidase gene.	ASAH2 ASAH2B	1.52e-05	2	136	2	12435403
Pubmed	Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney.	ASAH2 ASAH2B	1.52e-05	2	136	2	11328816
Pubmed	USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2.	USP8 NFE2L2	1.52e-05	2	136	2	37639742
Pubmed	PLK1 phosphorylation of pericentrin initiates centrosome maturation at the onset of mitosis.	PLK1 PCNT	1.52e-05	2	136	2	22184200
Pubmed	Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation.	ASAH2 ASAH2B	1.52e-05	2	136	2	19345744
Pubmed	Lactosylceramide contributes to mitochondrial dysfunction in diabetes.	ASAH2 ASAH2B	1.52e-05	2	136	2	26900161
Pubmed	Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.	TRAF3 TRAF5	1.52e-05	2	136	2	23329887
Pubmed	A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease.	ASAH2 ASAH2B	1.52e-05	2	136	2	17334805
Pubmed	Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5.	TRAF3 TRAF5	1.52e-05	2	136	2	23150880
Pubmed	Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death.	ASAH2 ASAH2B	1.52e-05	2	136	2	26747710
Pubmed	Molecular cloning of the full-length cDNA encoding mouse neutral ceramidase. A novel but highly conserved gene family of neutral/alkaline ceramidases.	ASAH2 ASAH2B	1.52e-05	2	136	2	10753931
Pubmed	Knockdown of Smox protects the integrity of the blood-brain barrier through antioxidant effect and Nrf2 pathway activation in stroke.	NFE2L2 SMOX	1.52e-05	2	136	2	37984250
Pubmed	Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression.	BRCA2 PLK1	1.52e-05	2	136	2	14647413
Pubmed	Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids.	ASAH2 ASAH2B	1.52e-05	2	136	2	16380386
Pubmed	Cytochrome P450 2E1-dependent oxidant stress and upregulation of anti-oxidant defense in liver cells.	TTF2 NFE2L2	1.52e-05	2	136	2	16958665
Pubmed	Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.	PTPN13 PTPRJ	1.52e-05	2	136	2	19672627
Pubmed	A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1.	PTPN13 ARHGAP29	1.52e-05	2	136	2	9305890
Pubmed	Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized.	ASAH2 ASAH2B	1.52e-05	2	136	2	10652340
Pubmed	Neutral ceramidase gene: role in regulating ceramide-induced apoptosis.	ASAH2 ASAH2B	1.52e-05	2	136	2	14557071
Pubmed	The human heat-shock genes HSPA6 and HSPA7 are both expressed and localize to chromosome 1.	HSPA6 HSPA7	1.52e-05	2	136	2	1346391
Pubmed	Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma.	NTRK3 NGFR	1.52e-05	2	136	2	31569361
Pubmed	Neutral ceramidase-dependent regulation of macrophage metabolism directs intestinal immune homeostasis and controls enteric infection.	ASAH2 ASAH2B	1.52e-05	2	136	2	35354041
Pubmed	Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu.	ASAH2 ASAH2B	1.52e-05	2	136	2	16126722
Pubmed	Binding of the RING polycomb proteins to specific target genes in complex with the grainyhead-like family of developmental transcription factors.	TFCP2 RNF2	1.52e-05	2	136	2	11865070
Pubmed	Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.	ASAH2 ASAH2B	1.52e-05	2	136	2	22940715
Pubmed	Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.	ASAH2 ASAH2B	1.52e-05	2	136	2	24659784
Pubmed	Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling.	TRAF3 PLK1	1.52e-05	2	136	2	27003818
Pubmed	Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA.	ASAH2 ASAH2B	1.52e-05	2	136	2	21613224
Pubmed	Expression of neurotrophin receptors in the developing and adult testis.	NTRK3 NGFR	1.52e-05	2	136	2	11322334
Pubmed	Plk1 interacts with RNF2 and promotes its ubiquitin‑dependent degradation.	RNF2 PLK1	1.52e-05	2	136	2	29565459
Pubmed	The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation.	NFE2L2 CHD6	1.52e-05	2	136	2	16314513
Pubmed	ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.	ANLN MKI67	1.52e-05	2	136	2	27863473
Pubmed	Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.	ASAH2 ASAH2B	1.52e-05	2	136	2	35151662
Pubmed	PLK1 regulation of PCNT cleavage ensures fidelity of centriole separation during mitotic exit.	PLK1 PCNT	1.52e-05	2	136	2	26647647
Pubmed	Identification of genetic drivers of plasma lipoprotein size in the Diversity Outbred mouse population.	ASAH2 ASAH2B	1.52e-05	2	136	2	37944753
Pubmed	Role of neutral ceramidase in colon cancer.	ASAH2 ASAH2B	1.52e-05	2	136	2	27609772
Pubmed	NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.	BRCA2 NFE2L2 CHD6	1.63e-05	13	136	3	28416489
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	ABCA13 PTPN13 DST UBAP2L MKI67 ZBTB10 LTBP1 PCNT	1.71e-05	284	136	8	29459677
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNRC6B LUZP1 PTPN13 DST ALMS1 BTF3 ARHGAP29	1.94e-05	209	136	7	36779422
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NRIP1 WASHC2C ARHGAP17 DDX1 LUZP1 RESF1 SMG7 ALMS1 BRCA2 ZMYM4 PCNT	2.13e-05	588	136	11	38580884
Pubmed	A human MAP kinase interactome.	EHBP1 EXPH5 ARHGAP17 TOX4 LATS1 DST ATXN1 AKAP13 CHD6 SOS2	2.29e-05	486	136	10	20936779
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NUSAP1 WASHC2C BMP2K DIDO1 ANKHD1 DNTTIP2 RNF215 PTPN13 RESF1 UBAP2L ANLN ZBTB10 ARHGEF3 DMWD PCNT	2.38e-05	1084	136	15	11544199
Pubmed	NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.	NGFR AKAP13 ARHGEF3 SOS2	2.45e-05	43	136	4	12376548
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	AFF3 CHD9 REV3L RESF1 BRCA2 PLK1 ZMYM4	2.85e-05	222	136	7	37071664
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	ZNF211 TRIM2 ANK2 DST RESF1 PDE4DIP	2.99e-05	151	136	6	17043677
Pubmed	FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development.	TRIM2 KLF5 MKI67	3.16e-05	16	136	3	21503901
Pubmed	Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.	NTRK3 MKI67 NGFR	3.16e-05	16	136	3	25433207
Pubmed	A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains.	TRAF3 TRAF5 NGFR	3.16e-05	16	136	3	11279055
Pubmed	Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.	NUSAP1 ANLN MKI67	3.16e-05	16	136	3	32469866
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	MYEF2 TENM4 CGN CHD6 IFT80 ARHGAP20	3.22e-05	153	136	6	10718198
Pubmed	Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.	FLG TRAF3 INSL5 TAF1C DIDO1 RSC1A1 DST MKI67	3.42e-05	313	136	8	20800603
Pubmed	Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins.	DIDO1 DAPK1 FANCM STN1 LATS1 LOXL2 PLK1	3.58e-05	230	136	7	29513927
Pubmed	A role for p75 neurotrophin receptor in the control of hair follicle morphogenesis.	NTRK3 MKI67 NGFR	3.82e-05	17	136	3	10588868
Pubmed	BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC.	BRCA2 PLK1	4.54e-05	3	136	2	24448238
Pubmed	The molecular circuitry regulating the switch between iron deficiency and overload in mice.	ASAH2 ASAH2B	4.54e-05	3	136	2	16418170
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 MKI67	4.54e-05	3	136	2	27163153
Pubmed	Identification of a functional hepatocyte nuclear factor 4 binding site in the neutral ceramidase promoter.	ASAH2 ASAH2B	4.54e-05	3	136	2	20803549
Pubmed	Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1.	ASAH2 ASAH2B	4.54e-05	3	136	2	12921776
Pubmed	Cpeb4-mediated Dclk2 promotes neuronal pyroptosis induced by chronic cerebral ischemia through phosphorylation of Ehf.	CPEB4 DCLK2	4.54e-05	3	136	2	38513137
Pubmed	Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma.	NTRK3 NGFR	4.54e-05	3	136	2	16826429
Pubmed	Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation.	PTPN13 NGFR	4.54e-05	3	136	2	10544233
Pubmed	The Barrier Molecules Junction Plakoglobin, Filaggrin, and Dystonin Play Roles in Melanoma Growth and Angiogenesis.	FLG DST	4.54e-05	3	136	2	31425296
Pubmed	LAF4 maps to mouse chromosome 1 and human chromosome 2q11.2-q12.	AFF3 DST	4.54e-05	3	136	2	8662235
Pubmed	Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages.	ASAH2 ASAH2B	4.54e-05	3	136	2	38302493
Interaction	PHF21A interactions	EHBP1 ZNF536 TNRC6B ANKHD1 LUZP1 TOX4 PTPN13 DST RESF1 RNF2 ALMS1 BRCA2 CHD6 HSPA6 PCNT	7.66e-09	343	132	15	int:PHF21A
Interaction	KDM1A interactions	EHBP1 TET2 NRIP1 TNRC6B ANKHD1 DDX1 LUZP1 PTPN13 DST RESF1 RNF2 SMG7 ALMS1 ZNF608 BRCA2 ATXN1 NFE2L2 PDE4DIP ARHGAP29 ZBTB10 CHD6 HSPA6 ZMYM4 PCNT	9.55e-09	941	132	24	int:KDM1A
Interaction	WWTR1 interactions	TTF2 TNRC6B DIDO1 DAPK1 ANKHD1 LUZP1 TOX4 PTPN13 LATS1 SMG7 ALMS1 ANLN KLF5 CGN PLK1 HSPA6	1.76e-08	422	132	16	int:WWTR1
Interaction	FXR2 interactions	TNRC6B OCRL TFCP2 DDX1 LUZP1 LATS1 L3MBTL1 RNF2 SMG7 UBAP2L ANLN BTF3 LOXL2 CPEB4 MKI67 ZBTB10	2.29e-08	430	132	16	int:FXR2
Interaction	RCOR1 interactions	EHBP1 ZNF536 TNRC6B ANKHD1 STN1 LUZP1 TOX4 PTPN13 DST RESF1 ALMS1 BRCA2 MKI67 CHD6 HSPA6 ZMYM4	1.54e-07	494	132	16	int:RCOR1
Interaction	HDAC1 interactions	EHBP1 TET2 NRIP1 ZNF536 TNRC6B ANKHD1 TFCP2 DDX1 LUZP1 TOX4 PTPN13 DST RNF2 ALMS1 ZNF608 BRCA2 ATXN1 ANLN NFE2L2 KLF5 BTF3 MKI67 HSPA6 PCNT	2.06e-07	1108	132	24	int:HDAC1
Interaction	CEP135 interactions	WASHC2C TNRC6B LUZP1 CCDC66 SMG7 ALMS1 BRCA2 CGN ARHGAP29 PLK1 ZMYM4 PCNT	2.38e-07	272	132	12	int:CEP135
Interaction	NINL interactions	TTF2 BMP2K TNRC6B LUZP1 PTPN13 CCDC66 LATS1 SMG7 ALMS1 BRCA2 MEIOC COMMD2 LTBP1 PLK1 PCNT	3.36e-07	458	132	15	int:NINL
Interaction	YWHAH interactions	EHBP1 TET2 NRIP1 EXPH5 ARHGAP17 DDX1 LUZP1 USP8 PTPN13 LATS1 SNCAIP DST RESF1 ALMS1 ATXN1 ANLN BTF3 CGN AKAP13 DCLK2 DMWD PLK1 PCNT	7.32e-07	1102	132	23	int:YWHAH
Interaction	PFN1 interactions	TTF2 ANK2 ARHGAP17 SIRPA OCRL ANKHD1 SMG7 ALMS1 ANLN BTF3 LOXL2 ARHGAP29 AKAP13 ZMYM4 PCNT	1.27e-06	509	132	15	int:PFN1
Interaction	MIB1 interactions	TNRC6B DAPK1 SNX19 LUZP1 PTPN13 CCDC66 SMG7 BTF3 ZBTB10 PLK1 PCNT	3.96e-06	295	132	11	int:MIB1
Interaction	CEP128 interactions	TTF2 IFT22 WASHC2C TNRC6B OCRL LUZP1 CCDC66 SMG7 ALMS1 ARHGAP29 PLK1	4.22e-06	297	132	11	int:CEP128
Interaction	FUBP3 interactions	TNRC6B DDX1 RNF2 SMG7 ATXN1 UBAP2L KLF5 CPEB4 MKI67 ZBTB10 SOS2	4.22e-06	297	132	11	int:FUBP3
Interaction	MYH14 interactions	TET2 TFCP2 LATS1 BRCA2 ANLN BTF3 LOXL2 MKI67 GNS	4.36e-06	189	132	9	int:MYH14
Interaction	NIN interactions	TTF2 TNRC6B LUZP1 CCDC66 LATS1 SMG7 ALMS1 BRCA2 MEIOC ANLN PLK1 PCNT	4.37e-06	359	132	12	int:NIN
Interaction	NAA40 interactions	EHBP1 TTF2 WASHC2C ANK2 TNRC6B DIDO1 OCRL ANKHD1 TFCP2 DNTTIP2 USP8 TOX4 PTPN13 DST SMG7 ALMS1 UBAP2L BTF3 MKI67 PCNT	5.76e-06	978	132	20	int:NAA40
Interaction	PHIP interactions	ZNF536 TNRC6B ANKHD1 MYEF2 RNF2 SMG7 ZNF608 ANLN CPEB4	6.11e-06	197	132	9	int:PHIP
Interaction	CEP120 interactions	TTF2 ANK2 TNRC6B LUZP1 CCDC66 ALMS1 BTF3	6.27e-06	106	132	7	int:CEP120
Interaction	SYNE3 interactions	EXPH5 TNRC6B OCRL SNX19 CCDC66 LATS1 DST SMG7 ALMS1 BRCA2 ARHGAP29 PLK1 PCNT	7.23e-06	444	132	13	int:SYNE3
Interaction	FXR1 interactions	TRAF3 TNRC6B DIDO1 OCRL ANKHD1 MYEF2 DDX1 LUZP1 SMG7 ATXN1 UBAP2L ANLN BTF3 LOXL2 CPEB4 ZBTB10	9.65e-06	679	132	16	int:FXR1
Interaction	ODF2 interactions	NRIP1 TRAF5 TNRC6B LUZP1 CCDC66 SMG7 ALMS1 PLK1	9.67e-06	158	132	8	int:ODF2
Interaction	CNTROB interactions	TTF2 TNRC6B DAPK1 LUZP1 LATS1 ALMS1 BTF3 PLK1	1.39e-05	166	132	8	int:CNTROB
Interaction	BEX3 interactions	TRAF3 TRAF5 NTRK3 PTPN13 NGFR	1.87e-05	50	132	5	int:BEX3
Interaction	YWHAG interactions	EHBP1 TET2 TRAF3 EXPH5 ARHGAP17 DNTTIP2 DDX1 LUZP1 USP8 PTPN13 LATS1 DST ALMS1 ATXN1 ANLN BTF3 CGN ARHGAP29 AKAP13 DCLK2 DMWD PLK1	1.95e-05	1248	132	22	int:YWHAG
Interaction	VIM interactions	TET2 TTF2 WASHC2C TNRC6B SIRPA OCRL TFCP2 LUZP1 TOX4 RESF1 RNF2 ATXN1 ANLN BTF3 CPEB4 PLK1 GNS	2.03e-05	804	132	17	int:VIM
Interaction	SQSTM1 interactions	TTF2 TRAF3 BMP2K INSL5 NTRK3 TNRC6B OCRL ANKHD1 LUZP1 USP8 SMG7 ALMS1 MEIOC ATXN1 UBAP2L ANLN NFE2L2 BTF3 CPEB4 NGFR PLK1 PCNT	2.18e-05	1257	132	22	int:SQSTM1
Interaction	PLEC interactions	TET2 BMP2K FANCM LUZP1 LATS1 DST BRCA2 ANLN BTF3 PDE4DIP FBXO43 PCNT	2.65e-05	430	132	12	int:PLEC
Interaction	GOLGA1 interactions	TTF2 WASHC2C PTPN13 DST SMG7 ALMS1 ARHGAP29 PCNT	2.80e-05	183	132	8	int:GOLGA1
Interaction	PCM1 interactions	TTF2 IFT22 LUZP1 CCDC66 LATS1 SMG7 ATXN1 BTF3 COMMD2 MINDY4 PLK1 PCNT	2.90e-05	434	132	12	int:PCM1
Interaction	TUBB6 interactions	NTRK3 TFCP2 FOCAD LATS1 L3MBTL1 ANLN BTF3 MINDY4 ZMYM4	3.25e-05	243	132	9	int:TUBB6
Interaction	ACTR3 interactions	ZNF536 WASHC2C TNRC6B ARHGAP17 DAPK1 DST ALMS1 ATXN1 ANLN BTF3	3.34e-05	305	132	10	int:ACTR3
Interaction	TRAF3IP1 interactions	TRAF3 IFT22 DST IFT80 HSPA6 PCNT	4.03e-05	96	132	6	int:TRAF3IP1
Interaction	AMOT interactions	WASHC2C TNRC6B ARHGAP17 TFCP2 PTPN13 LATS1 SMG7 ALMS1 CGN PCNT	4.04e-05	312	132	10	int:AMOT
Interaction	BICD1 interactions	IFT22 TNRC6B OCRL LUZP1 SMG7 ANLN ARHGAP29 MINDY4 PLK1	4.06e-05	250	132	9	int:BICD1
Interaction	LSM14A interactions	TNRC6B ARHGAP17 DDX1 SMG7 UBAP2L ANLN KLF5 CPEB4 ZBTB10	5.50e-05	260	132	9	int:LSM14A
Interaction	NUP43 interactions	TNRC6B CHD9 DNTTIP2 DST RESF1 RNF2 ZNF608 BRCA2 MKI67 ZBTB10 CHD6 TRMT1L HSPA6 ZMYM4	6.23e-05	625	132	14	int:NUP43
Interaction	ZYX interactions	ANK2 BMP2K TNRC6B LUZP1 LATS1 SMG7 ALMS1 ATXN1 AKAP13 PCNT	6.30e-05	329	132	10	int:ZYX
Interaction	TBR1 interactions	TET2 ZNF536 LATS1 ZNF608 ATXN1 ZMYM4	1.00e-04	113	132	6	int:TBR1
Interaction	CLTA interactions	TET2 WASHC2C BMP2K TNRC6B OCRL DNTTIP2 ALMS1 ANLN BTF3 HSPA6	1.08e-04	351	132	10	int:CLTA
Interaction	RTRAF interactions	DDX1 UBAP2L ANLN BTF3 CPEB4 ARHGAP29 ZBTB10 PCNT	1.09e-04	222	132	8	int:RTRAF
Interaction	ABI1 interactions	NTRK3 DST ATXN1 BTF3 MKI67 HSPA6 HSPA7 SOS2	1.13e-04	223	132	8	int:ABI1
Interaction	SEC16A interactions	TRAF3 BMP2K TNRC6B ANKHD1 LATS1 RNF2 SMG7 ANLN KLF5 BTF3 CHD6	1.16e-04	426	132	11	int:SEC16A
Interaction	NGFR interactions	TRAF3 TRAF5 NTRK3 PTPN13 NGFR	1.17e-04	73	132	5	int:NGFR
Interaction	TJP2 interactions	TTF2 ARHGAP17 LUZP1 LATS1 SMG7 ALMS1 ANLN BTF3 CGN	1.20e-04	288	132	9	int:TJP2
Interaction	EGR2 interactions	TET2 ZNF536 RESF1 ZNF608 ATXN1 PDE4DIP ZMYM4	1.36e-04	171	132	7	int:EGR2
Interaction	POC1A interactions	MDM1 LUZP1 CCDC66 BTF3 COMMD2 HSPA6	1.53e-04	122	132	6	int:POC1A
Interaction	UBAP2L interactions	TNRC6B DDX1 SMG7 ATXN1 UBAP2L ANLN BTF3 CPEB4 ZBTB10	1.55e-04	298	132	9	int:UBAP2L
Interaction	EIF4ENIF1 interactions	TNRC6B DAPK1 ANKHD1 DDX1 DST SMG7 ATXN1 UBAP2L CPEB4	1.63e-04	300	132	9	int:EIF4ENIF1
Interaction	FAM98A interactions	PLEKHM1 DDX1 TOX4 ATXN1 UBAP2L BTF3 CPEB4 ZBTB10	1.71e-04	237	132	8	int:FAM98A
Interaction	CNOT2 interactions	TNRC6B ANKHD1 SMG7 ALMS1 ATXN1 UBAP2L CPEB4	1.74e-04	178	132	7	int:CNOT2
Interaction	PRELID2 interactions	EXPH5 ALMS1 BRCA2	1.75e-04	17	132	3	int:PRELID2
Interaction	LCA5 interactions	IFT22 TRIM2 LUZP1 CCDC66 IFT80 PLK1	1.75e-04	125	132	6	int:LCA5
Interaction	CEP152 interactions	TTF2 TNRC6B LUZP1 LATS1 SMG7 ALMS1 PCNT	1.80e-04	179	132	7	int:CEP152
Interaction	SFN interactions	TET2 EXPH5 NTRK3 LUZP1 USP8 PTPN13 LATS1 DST ALMS1 ATXN1 ANLN LOXL2 CGN AKAP13	1.81e-04	692	132	14	int:SFN
Interaction	KCNA3 interactions	EHBP1 TTF2 NRIP1 ANK2 ABCA13 EXPH5 TNRC6B CHD9 OCRL LUZP1 PTPN13 LATS1 DST UBAP2L CGN ARHGAP29	1.87e-04	871	132	16	int:KCNA3
Interaction	CAPRIN1 interactions	TNRC6B DAPK1 RNF2 SMG7 ATXN1 UBAP2L ANLN BTF3 MKI67 ZBTB10 TRMT1L	1.90e-04	451	132	11	int:CAPRIN1
Interaction	CPAP interactions	TNRC6B LATS1 SMG7 ALMS1 BTF3 PLK1 PCNT	1.99e-04	182	132	7	int:CPAP
Interaction	EYA4 interactions	TET2 TNRC6B LUZP1 RESF1 ALMS1 ZNF608 BRCA2 PLK1	2.03e-04	243	132	8	int:EYA4
Interaction	R3HDM2 interactions	TNRC6B DDX1 SMG7 ATXN1 UBAP2L CPEB4	2.07e-04	129	132	6	int:R3HDM2
Interaction	YTHDF3 interactions	TNRC6B ANKHD1 DDX1 SMG7 UBAP2L KLF5 CPEB4 MKI67	2.21e-04	246	132	8	int:YTHDF3
Interaction	MLF2 interactions	ZNF211 LATS1 L3MBTL1 ATXN1 ANLN HSPA6	2.25e-04	131	132	6	int:MLF2
Interaction	R3HDM1 interactions	LATS1 SMG7 ATXN1 UBAP2L CPEB4	2.28e-04	84	132	5	int:R3HDM1
Interaction	ENTR1 interactions	TTF2 TNRC6B PTPN13 LATS1 SMG7 ALMS1 PLK1	2.43e-04	188	132	7	int:ENTR1
Interaction	TRIM52 interactions	EXPH5 STN1 ALMS1 BRCA2 MEIOC PCNT	2.45e-04	133	132	6	int:TRIM52
Interaction	WDR49 interactions	ARHGAP17 L3MBTL1	2.53e-04	4	132	2	int:WDR49
Interaction	STIL interactions	WASHC2C TNRC6B SMG7 ALMS1 BTF3 CGN PCNT	2.59e-04	190	132	7	int:STIL
Interaction	MAD2L1 interactions	NTRK3 CHD9 REV3L FANCM LUZP1 RNF2 ATXN1 BTF3	2.60e-04	252	132	8	int:MAD2L1
Interaction	EZR interactions	EHBP1 TRAF3 ANK2 OCRL PALMD LUZP1 DST ANLN LOXL2 COMMD2 FBXO43 SEL1L2	2.85e-04	553	132	12	int:EZR
Interaction	MYO1D interactions	ANK2 DAPK1 TFCP2 ANLN BTF3 LOXL2 HSPA6	2.94e-04	194	132	7	int:MYO1D
Interaction	QPCTL interactions	NTRK3 OCRL LATS1 RNF2 ANLN	2.99e-04	89	132	5	int:QPCTL
Interaction	CEP104 interactions	TNRC6B LUZP1 CCDC66 ALMS1 PLK1	2.99e-04	89	132	5	int:CEP104
Interaction	KLF5 interactions	TET2 FLG ZNF608 ATXN1 KLF5 ZBTB10 ZMYM4	3.03e-04	195	132	7	int:KLF5
Interaction	ATAD3A interactions	TFCP2 LATS1 L3MBTL1 RNF2 ANLN KLF5 BTF3 LOXL2 MKI67	3.30e-04	330	132	9	int:ATAD3A
Interaction	YWHAB interactions	TET2 EXPH5 DAPK1 TFCP2 LUZP1 USP8 PTPN13 LATS1 DST ATXN1 ANLN BTF3 CGN AKAP13 DCLK2 DMWD GNS	3.40e-04	1014	132	17	int:YWHAB
Interaction	C6orf141 interactions	EXPH5 ANKHD1 SMG7 ALMS1 BRCA2	3.48e-04	92	132	5	int:C6orf141
Interaction	PRRC2B interactions	TNRC6B DAPK1 ANKHD1 SMG7 ATXN1 UBAP2L KLF5 CPEB4	3.64e-04	265	132	8	int:PRRC2B
Interaction	YWHAQ interactions	TET2 NRIP1 EXPH5 DAPK1 TFCP2 DDX1 LUZP1 USP8 PTPN13 LATS1 DST ATXN1 ANLN BTF3 CGN AKAP13 DCLK2 DMWD	3.67e-04	1118	132	18	int:YWHAQ
Interaction	MYH3 interactions	ASAH2 LATS1 ANLN MKI67	3.73e-04	52	132	4	int:MYH3
Interaction	PTPN13 interactions	NTRK3 PTPN13 LATS1 PTPRJ CGN ARHGAP29 NGFR	3.75e-04	202	132	7	int:PTPN13
Interaction	G3BP1 interactions	TNRC6B DDX1 LUZP1 DST RNF2 SMG7 UBAP2L ANLN CSNK1G2 KLF5 BTF3 CPEB4 MKI67 ZBTB10 GNS	3.80e-04	835	132	15	int:G3BP1
Interaction	SLX4 interactions	AFF3 DIDO1 CHD9 REV3L ANKHD1 TOX4 RESF1 BRCA2 MKI67 PLK1 HSPA6 ZMYM4	3.86e-04	572	132	12	int:SLX4
Interaction	DAZL interactions	TRAF3 TNRC6B DDX1 SMG7 UBAP2L CPEB4	3.89e-04	145	132	6	int:DAZL
Interaction	MEN1 interactions	WASHC2C TAF1C DIDO1 TFCP2 MYEF2 DNTTIP2 DDX1 LUZP1 TOX4 ZNF608 BRCA2 ANLN MKI67 ZBTB10 TRMT1L PLK1 ZMYM4	4.03e-04	1029	132	17	int:MEN1
Interaction	TEDC2 interactions	PTPN13 DST UBAP2L MKI67 ZBTB10 LTBP1 PCNT	4.22e-04	206	132	7	int:TEDC2
Interaction	NUAK1 interactions	DDX1 LATS1 UBAP2L MKI67 PLK1	4.24e-04	96	132	5	int:NUAK1
Interaction	MYO1B interactions	NTRK3 DAPK1 TFCP2 LATS1 ATXN1 ANLN BTF3 LOXL2	4.43e-04	273	132	8	int:MYO1B
Interaction	OFD1 interactions	EHBP1 TNRC6B LUZP1 LATS1 SMG7 ANLN COMMD2 PLK1 PCNT	4.75e-04	347	132	9	int:OFD1
Interaction	TERF1 interactions	NRIP1 BMP2K TOX4 DST RNF2 BRCA2 ARHGEF3 PLK1 HSPA6	4.75e-04	347	132	9	int:TERF1
Interaction	RNF43 interactions	EHBP1 EXPH5 TNRC6B PTPN13 SMG7 ALMS1 MEIOC CPEB4 MKI67 HSPA6	5.15e-04	427	132	10	int:RNF43
Interaction	YWHAE interactions	TET2 EXPH5 CFAP43 FRMD4B LUZP1 USP8 PTPN13 LATS1 DST ATXN1 ANLN BTF3 LOXL2 CGN AKAP13 LTBP1 DCLK2 MINDY4 DMWD	5.39e-04	1256	132	19	int:YWHAE
Interaction	HDAC2 interactions	NUSAP1 TET2 NRIP1 BMP2K TFCP2 DDX1 RNF2 BRCA2 NFE2L2 KLF5 BTF3 MKI67 LTBP1 PLK1 GNS	5.48e-04	865	132	15	int:HDAC2
Interaction	KRT19 interactions	TNRC6B TFCP2 LUZP1 SMG7 ALMS1 ATXN1 BTF3 PCNT	5.49e-04	282	132	8	int:KRT19
Interaction	MCM3 interactions	NUSAP1 DIDO1 L3MBTL1 ATXN1 ANLN BTF3 LOXL2 MKI67 PLK1	5.60e-04	355	132	9	int:MCM3
Interaction	ETV6 interactions	TRAF3 TNRC6B L3MBTL1 ALMS1 NFE2L2	6.39e-04	105	132	5	int:ETV6
Interaction	LATS1 interactions	TET2 TNRC6B PTPN13 LATS1 SMG7 ALMS1 LOXL2 CGN PLK1 PCNT	6.49e-04	440	132	10	int:LATS1
GeneFamily	CD molecules\|V-set domain containing\|C1-set domain containing\|Signal regulatory proteins	SIRPB2 SIRPA	2.32e-04	5	88	2	747
GeneFamily	TNF receptor associated factors	TRAF3 TRAF5	4.84e-04	7	88	2	1056
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG RPTN	4.84e-04	7	88	2	1350
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP17 ARHGAP29 ARHGAP20	1.85e-03	50	88	3	721
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF536 ZFP90 ZNF211 ZNF215 ZNF302 ZNF35 ZNF608 KLF5 ZBTB10 ZNF107	2.53e-03	718	88	10	28
GeneFamily	Heat shock 70kDa proteins	HSPA6 HSPA7	3.04e-03	17	88	2	583
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	AKAP13 ARHGEF3 SOS2	4.09e-03	66	88	3	722
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCM BRCA2	4.20e-03	20	88	2	548
GeneFamily	Intraflagellar transport proteins\|Tetratricopeptide repeat domain containing	IFT22 IFT80	6.03e-03	24	88	2	615
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6B MAML3	6.53e-03	25	88	2	775
GeneFamily	Ankyrin repeat domain containing	ANK2 DAPK1 ANKHD1 SNCAIP ANKRD30A	6.56e-03	242	88	5	403
Coexpression	HALLMARK_MITOTIC_SPINDLE	NUSAP1 LATS1 DST ALMS1 BRCA2 ANLN ARHGAP29 AKAP13 ARHGEF3 PLK1 PCNT	6.67e-09	199	134	11	M5893
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EHBP1 NRIP1 TRIM2 BMP2K DAPK1 CHD9 REV3L ZNF804A PTPN13 DST RNF2 BRCA2 ATXN1 ARHGAP29 AKAP13 ZMYM4 PCNT SOS2	3.92e-07	856	134	18	M4500
Coexpression	YAGI_AML_WITH_INV_16_TRANSLOCATION	TRAF5 EXPH5 DIDO1 FRMD4B TFCP2 USP8 PTPRJ BRCA2 FKTN AKAP13 HSPA6 GNS	1.42e-06	411	134	12	M1047
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP	NUSAP1 EHBP1 CADM4 REV3L FANCM ZFAND4 MYEF2 ALMS1 BRCA2 ANLN MKI67 DCLK2 IFT80 ARHGAP20 PLK1	2.20e-06	680	134	15	MM456
Coexpression	GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN	ZFP90 LATS1 BRCA2 NFE2L2 PDE4DIP PLK1 ZMYM4 PCNT	8.83e-06	199	134	8	M7099
Coexpression	GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP	INSL5 REV3L ADGRG2 FKTN FBXO43 IFT80 ARHGAP20 SOS2	9.16e-06	200	134	8	M7776
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP	ZNF536 ZNF211 BMP2K TNRC6B RNF2 ALMS1 ATXN1 CPEB4 PCNX1 AKAP13 CHD6 IFT80 SMOX MAML3 GNS	1.11e-05	778	134	15	M17915
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 EXPH5 ZNF804A PTPN13 DST CPEB4 ARHGEF3 MAML3	1.40e-05	212	134	8	M39221
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	ANK2 MAN1C1 DAPK1 ZNF804A SNX19 DNTTIP2 DDX1 BRCA2 ATXN1 ANLN NFE2L2 KLF5 LOXL2 PDE4DIP ARHGAP29 CHD6 ARHGEF3	1.60e-05	1009	134	17	M157
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	WASHC2C INHBA RSC1A1 PLEKHM1 ABHD5 DST RESF1 NFE2L2 KLF5 PDE4DIP PCNX1 ARHGEF3 SMOX HSPA6 SOS2	2.10e-05	822	134	15	M6782
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	FLG NRIP1 EXPH5 DIDO1 CHD9 REV3L DST NFE2L2 MKI67	2.50e-05	300	134	9	M8702
Coexpression	GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN	BMP2K SIRPA LAX1 ABHD5 PTPRJ ATXN1 GNS	2.81e-05	170	134	7	M8188
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	NUSAP1 NRIP1 TRIM2 ZNF302 REV3L ANKHD1 MYEF2 USP8 PTPN13 RESF1 ANLN MKI67 ZNF107	3.32e-05	656	134	13	M18979
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	TRAF3 BMP2K MAN1C1 FOCAD RNF2 ATXN1 IFT80	4.04e-05	180	134	7	M9145
Coexpression	YU_MYC_TARGETS_UP	BRCA2 ANLN MKI67 PLK1	6.29e-05	42	134	4	MM1150
Coexpression	YU_MYC_TARGETS_UP	BRCA2 ANLN MKI67 PLK1	6.90e-05	43	134	4	M1249
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	TET2 NRIP1 WASHC2C CADM4 AFF3 DAPK1 SIRPB2 OCRL TNFRSF10C RSC1A1 FRMD4B PLEKHM1 USP8 ABHD5 NFE2L2 CPEB4 ISG20L2 MAML3	6.97e-05	1250	134	18	M41099
Coexpression	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	NRIP1 ANK2 INHBA MAN1C1 FRMD4B ADGRG2 LOXL2 ZBTB10 AKAP13 HSPA6	7.18e-05	427	134	10	M17923
Coexpression	GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	NRIP1 FRMD4B STN1 PTPN13 DST PDE4DIP MAML3	7.61e-05	199	134	7	M8622
Coexpression	GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP	NRIP1 ZFP90 LAX1 ZNF608 PTPRJ CSNK1G2 DMWD	7.61e-05	199	134	7	M6973
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP	GPR155 TNRC6B ZFAND4 AKAP13 ARHGEF3 PLK1 PCNT	7.86e-05	200	134	7	M8050
Coexpression	GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN	NRIP1 TRAF5 ABCA13 RNF215 SNCAIP ANLN PCNX1	7.86e-05	200	134	7	M3491
Coexpression	GSE30083_SP2_VS_SP4_THYMOCYTE_UP	ANK2 EXPH5 TENM4 ZNF608 ADGRA1 ARHGAP20 DMWD	7.86e-05	200	134	7	M5034
Coexpression	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP	TAF1C MDM1 TNRC6B DIDO1 ZFAND4 RESF1 RNF2	7.86e-05	200	134	7	M6447
Coexpression	ODONNELL_TFRC_TARGETS_DN	ZFAND4 TOX4 BRCA2 ANLN MKI67 PLK1	8.21e-05	139	134	6	M6451
Coexpression	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP	ZNF536 ZNF211 BMP2K TNRC6B RNF2 ALMS1 ATXN1 CPEB4 PCNX1 AKAP13 CHD6 IFT80 SMOX MAML3 GNS	9.83e-05	942	134	15	M8144
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P7	NTRK3 DST RESF1 IFT80 ARHGAP20	1.06e-04	91	134	5	M1736
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P7	NTRK3 DST RESF1 IFT80 ARHGAP20	1.17e-04	93	134	5	MM1218
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	TTF2 SIRPA REV3L FAH DST ALMS1 PDE4DIP AKAP13	1.27e-04	290	134	8	M13251
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	EHBP1 ANK2 TNRC6B CHD9 FRMD4B PTPRJ AKAP13	1.46e-04	221	134	7	M39222
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	EHBP1 NRIP1 TRIM2 DAPK1 CHD9 REV3L ZNF804A DST ARHGAP29 ZMYM4	1.47e-04	466	134	10	M13522
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	TET2 NRIP1 INHBA AFF3 TNRC6B CHD9 ANKHD1 PTPRJ UBAP2L ARHGAP29	1.49e-04	467	134	10	M1347
Coexpression	FAN_EMBRYONIC_CTX_MICROGLIA_1	NUSAP1 TTF2 BRCA2 ANLN MKI67 PLK1	1.49e-04	155	134	6	M39041
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	WASHC2C BMP2K ARHGAP17 DAPK1 CHD9 OCRL ANKHD1 TFCP2 DNTTIP2 STN1 ATXN1 UBAP2L PDE4DIP ZBTB10 GNS ZMYM4 SOS2	1.59e-04	1215	134	17	M41122
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	CHD9 SNX19 PTPN13 DST ATXN1 BTF3 AKAP13	1.68e-04	226	134	7	M11238
Coexpression	BROWNE_HCMV_INFECTION_20HR_DN	TRIM2 REV3L PTPN13 DST LTBP1	1.81e-04	102	134	5	M5601
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	TET2 NRIP1 INHBA AFF3 TNRC6B CHD9 ANKHD1 PTPRJ UBAP2L ARHGAP29	1.99e-04	484	134	10	MM999
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GPR155 TRAF5 MAN1C1 TNRC6B REV3L LAX1 DNTTIP2 STN1 LUZP1 LATS1 RESF1 PTPRJ ATXN1 CSNK1G2 BTF3 PDE4DIP PCNX1 AKAP13 ARHGEF3	2.15e-04	1492	134	19	M40023
Coexpression	IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	EHBP1 NRIP1 PALMD LOXL2 ARHGAP29	2.27e-04	107	134	5	M4913
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	NUSAP1 TET2 TTF2 NRIP1 BRCA2 ANLN MKI67 PLK1	2.65e-04	323	134	8	M2156
Coexpression	HEVNER_CORTEX_PROLIFERATING_CELLS	NUSAP1 MKI67 PLK1	2.77e-04	25	134	3	MM433
Coexpression	GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	NUSAP1 OCRL FOCAD TOX4 DST ATXN1	2.79e-04	174	134	6	M9007
Coexpression	GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR	NUSAP1 PALMD ANLN MKI67 ARHGAP29	2.92e-04	113	134	5	M39153
Coexpression	GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN	MAN1C1 USP8 DST CPEB4 ARHGEF3 GNS	2.97e-04	176	134	6	M6757
Coexpression	GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN	ZFAND4 PTPN13 ABHD5 PTPRJ ATXN1 SOS2	3.35e-04	180	134	6	M6317
Coexpression	GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP	ZFAND4 PTPN13 ABHD5 PTPRJ ATXN1 GNS	3.45e-04	181	134	6	M6323
Coexpression	REICHERT_MITOSIS_LIN9_TARGETS	NUSAP1 MKI67 PLK1	3.49e-04	27	134	3	M2483
Coexpression	PLASARI_TGFB1_TARGETS_10HR_DN	NUSAP1 TRIM2 PALMD ZNF608 ADGRG2 MKI67 ARHGAP20	3.75e-04	258	134	7	M2446
Coexpression	GSE6259_CD4_TCELL_VS_CD8_TCELL_DN	TET2 ARHGAP17 CHD9 FRMD4B PLEKHM1 SOS2	3.77e-04	184	134	6	M6739
Coexpression	GLINSKY_CANCER_DEATH_UP	RNF2 MKI67	3.84e-04	6	134	2	MM1267
Coexpression	REICHERT_MITOSIS_LIN9_TARGETS	NUSAP1 MKI67 PLK1	3.90e-04	28	134	3	MM1323
Coexpression	HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	NUSAP1 BRCA2 ANLN MKI67	4.13e-04	68	134	4	M41108
Coexpression	MARTINEZ_RB1_TARGETS_UP	WASHC2C CHD9 SIRPA FRMD4B FAH PTPN13 TENM4 UBAP2L RPTN PDE4DIP MKI67 PLK1	4.33e-04	741	134	12	MM1037
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2B	NUSAP1 NTRK3 TAF1C SNCAIP MKI67 LTBP1 DCLK2 HSPA6 HSPA7	4.41e-04	439	134	9	M39054
Coexpression	FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	NUSAP1 EXPH5 BRCA2 ANLN MKI67 PLK1	4.46e-04	190	134	6	M761
Coexpression	FISCHER_DREAM_TARGETS	NUSAP1 EHBP1 TTF2 MDM1 FANCM RNF2 ALMS1 BRCA2 ANLN MKI67 IFT80 ZNF107 PLK1 PCNT	4.53e-04	969	134	14	M149
Coexpression	SCHLOSSER_SERUM_RESPONSE_UP	TNRC6B L3MBTL1 BRCA2 CSNK1G2 BTF3	4.82e-04	126	134	5	M16381
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM	NUSAP1 TENM4 BRCA2 ANLN LOXL2 MKI67 LTBP1 PLK1	4.87e-04	354	134	8	M39061
Coexpression	PLASARI_TGFB1_TARGETS_10HR_DN	NUSAP1 TRIM2 PALMD ZNF608 ADGRG2 MKI67 ARHGAP20	5.03e-04	271	134	7	MM1075
Coexpression	PEREZ_TP63_TARGETS	MAN1C1 PALMD TNFRSF10C LUZP1 PTPRJ PDE4DIP NGFR HSPA6	5.06e-04	356	134	8	M10761
Coexpression	GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP	NRIP1 PLEKHM1 DNTTIP2 CCDC66 ABHD5 ZBTB10	5.26e-04	196	134	6	M4244
Coexpression	GLINSKY_CANCER_DEATH_UP	RNF2 MKI67	5.36e-04	7	134	2	M13007
Coexpression	ERBB2_UP.V1_DN	EHBP1 NRIP1 FKTN ARHGAP29 ZBTB10 ZNF107	5.40e-04	197	134	6	M2635
Coexpression	GSE13229_MATURE_VS_INTMATURE_NKCELL_DN	ZFP90 MDM1 ANKHD1 NFE2L2 ARHGEF3 PCNT	5.55e-04	198	134	6	M3216
Coexpression	GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	TRIM2 MAN1C1 TAF1C DIDO1 ATXN1 ARHGAP29	5.55e-04	198	134	6	M8624
Coexpression	GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP	TRIM2 MYEF2 RNF215 FAH ALMS1 CHD6	5.55e-04	198	134	6	M7200
Coexpression	GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN	NUSAP1 MAN1C1 SIRPA TENM4 ANLN MKI67	5.70e-04	199	134	6	M5983
Coexpression	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	TTF2 COL6A3 TRAF3 BMP2K DAPK1 FOCAD	5.70e-04	199	134	6	M3474
Coexpression	GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN	TRIM2 TENM4 RNF2 ATXN1 ARHGAP29 LTBP1	5.70e-04	199	134	6	M3479
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP	IFT22 BMP2K ARHGAP17 CHD9 PLEKHM1 DCLK2	5.70e-04	199	134	6	M7156
Coexpression	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN	TRAF5 BMP2K ASAH2 AFF3 TFCP2 ARHGAP29	5.70e-04	199	134	6	M9288
Coexpression	FIRESTEIN_CTNNB1_PATHWAY	LATS1 DCLK2 PLK1	5.81e-04	32	134	3	M1489
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN	NUSAP1 GPR155 IFT22 BMP2K AFF3 ARHGAP17	5.85e-04	200	134	6	M5966
Coexpression	GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP	SIRPA REV3L UBAP2L MKI67 ZBTB10 SOS2	5.85e-04	200	134	6	M5994
Coexpression	GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP	TRAF5 NTRK3 RESF1 RPTN ZBTB10 PCNX1	5.85e-04	200	134	6	M3523
Coexpression	GSE27786_NKTCELL_VS_NEUTROPHIL_UP	ZFP90 REV3L MYEF2 LAX1 ZMYM4 PCNT	5.85e-04	200	134	6	M4868
Coexpression	GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN	COL6A3 ZFP90 SIRPA TFCP2 PDE4DIP ARHGEF3	5.85e-04	200	134	6	M8217
Coexpression	GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN	GPR155 CHD9 PTPRJ PDE4DIP AKAP13 CHD6	5.85e-04	200	134	6	M7150
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN	NRIP1 EXPH5 AFF3 LUZP1 ZNF608 ARHGAP29	5.85e-04	200	134	6	M7518
Coexpression	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN	TET2 TRAF3 SIRPA PDE4DIP AKAP13 IFT80	5.85e-04	200	134	6	M6042
Coexpression	GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	ABCA13 MDM1 TNRC6B ZFAND4 ZNF608 AKAP13	5.85e-04	200	134	6	M6477
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	BMP2K FRMD4B RESF1 ATXN1 NFE2L2 AKAP13	5.85e-04	200	134	6	M6247
Coexpression	GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP	MAN1C1 TFCP2 LATS1 SMG7 MEIOC ZMYM4	5.85e-04	200	134	6	M6266
Coexpression	GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN	TET2 BMP2K REV3L AKAP13 ARHGEF3 SMOX	5.85e-04	200	134	6	M6943
Coexpression	GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	ASAH2 SIRPA FAH BRCA2 DCLK2 MINDY4	5.85e-04	200	134	6	M6996
Coexpression	GREENBAUM_E2A_TARGETS_UP	NUSAP1 ANLN MKI67	6.37e-04	33	134	3	M1490
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	NRIP1 TNRC6B CHD9	6.37e-04	33	134	3	M1359
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	NUSAP1 COL6A3 ZNF536 TRAF3 ANK2 INHBA FANCM MYEF2 DNTTIP2 LUZP1 CCDC66 LATS1 ALMS1 PTPRJ BRCA2 ATXN1 KLF5 CGN ADGRA1 CHD6 ARHGAP20 PCNT	2.23e-07	983	134	22	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	NTRK3 MDM1 OCRL LUZP1 CCDC66 LATS1 BRCA2 NFE2L2 MKI67 ADGRA1 IFT80 MAML3	3.33e-07	291	134	12	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NUSAP1 MDM1 REV3L ANKHD1 LUZP1 CCDC66 LATS1 ALMS1 BRCA2 MKI67 ADGRA1 IFT80	6.75e-07	311	134	12	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	TRAF3 MDM1 TNRC6B OCRL REV3L ANKHD1 PLEKHM1 STN1 LUZP1 CCDC66 LATS1 BRCA2 NFE2L2 MKI67 ADGRA1 IFT80 MAML3 ZMYM4	2.06e-06	780	134	18	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	NUSAP1 ZNF536 MDM1 LUZP1 CCDC66 LATS1 ALMS1 BRCA2 MKI67	2.85e-06	186	134	9	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	GPR155 COL6A3 IFT22 NTRK3 MDM1 OCRL REV3L TFCP2 PLEKHM1 LUZP1 CCDC66 LATS1 BRCA2 NFE2L2 MKI67 NGFR ADGRA1 LTBP1 IFT80 MAML3	3.74e-06	985	134	20	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	NUSAP1 TTF2 MDM1 FANCM DNTTIP2 LUZP1 DST RNF2 ALMS1 BRCA2 ANLN TRMT1L MAML3	8.81e-06	469	134	13	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	COL6A3 INHBA AFF3 MUC16 DAPK1 PALMD FRMD4B TFCP2 FAH PTPN13 SNCAIP TENM4 RESF1 LOXL2 CGN ARHGAP29 ARHGAP20	1.14e-05	797	134	17	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	NUSAP1 COL6A3 ZNF536 INHBA MDM1 RSC1A1 DDX1 LUZP1 CCDC66 LATS1 HMCN2 ALMS1 PTPRJ BRCA2 ATXN1 KLF5 MKI67 IFT80 ARHGAP20	1.25e-05	978	134	19	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	NUSAP1 ZNF536 TRAF3 MDM1 REV3L ANKHD1 LUZP1 CCDC66 LATS1 SMG7 ALMS1 BRCA2 KLF5 MKI67 ZBTB10 ADGRA1 IFT80 MAML3 PCNT	1.46e-05	989	134	19	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	COL6A3 BMP2K INHBA AFF3 MUC16 DAPK1 PALMD REV3L PTPN13 TENM4 RESF1 LOXL2 CGN ARHGAP29 LTBP1 ARHGAP20	1.78e-05	740	134	16	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1	NUSAP1 ABCA13 AFF3 SIRPB2 SIRPA ZFAND4 ZNF608 ANLN MKI67 PLK1 MAML3	4.27e-05	395	134	11	GSM538351_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	COL6A3 INHBA CADM4 AFF3 MUC16 DAPK1 PALMD FRMD4B TFCP2 FAH PTPN13 TENM4 RESF1 CGN ARHGAP29 ARHGAP20	4.36e-05	797	134	16	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3	NUSAP1 TTF2 MDM1 MYEF2 ALMS1 BRCA2 ANLN MKI67 DCLK2 IFT80 PLK1	4.57e-05	398	134	11	GSM399397_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NUSAP1 ZNF536 TRAF3 ZFAND4 DNTTIP2 CCDC66 LATS1 DST ALMS1 ATXN1 AKAP13 ADGRA1 CHD6 PCNT	6.85e-05	654	134	14	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	NUSAP1 MDM1 REV3L ZFAND4 LUZP1 CCDC66 SNCAIP BRCA2 NFE2L2 MKI67 MAML3	9.51e-05	432	134	11	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3	GPR155 TRAF5 BMP2K AFF3 ARHGAP17 FANCM LAX1 ZNF608 PTPRJ DCLK2	1.00e-04	361	134	10	GSM538219_500
CoexpressionAtlas	B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3	GPR155 TRAF5 BMP2K AFF3 ARHGAP17 LAX1 ZNF608 PTPRJ DCLK2 ARHGEF3	1.15e-04	367	134	10	GSM399440_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	NUSAP1 COL6A3 MDM1 REV3L LUZP1 BRCA2 MKI67 ADGRA1 MAML3	1.18e-04	298	134	9	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	EHBP1 TET2 COL6A3 INHBA AFF3 MUC16 PALMD REV3L FRMD4B SNCAIP TENM4 ANLN LOXL2 MKI67 ARHGAP20	1.18e-04	777	134	15	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	COL6A3 BMP2K AFF3 MUC16 DAPK1 REV3L FRMD4B PTPN13 TENM4 RESF1 CGN ARHGAP29 LTBP1 IFT80 ARHGAP20	1.29e-04	783	134	15	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	TTF2 ARHGAP17 FANCM DNTTIP2 LUZP1 SMG7 ALMS1 BRCA2 ANLN TRMT1L MAML3 PCNT	1.43e-04	532	134	12	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	AFF3 DAPK1 REV3L PTPN13 RESF1 CGN LTBP1	2.14e-04	191	134	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3	MDM1 REV3L ZFAND4 CCDC66 SNCAIP BRCA2 NFE2L2 MKI67	2.20e-04	255	134	8	Facebase_RNAseq_e10.5_Maxillary Arch_500_K3
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	COL6A3 AFF3 MUC16 DAPK1 REV3L FRMD4B PTPN13 TENM4 ANLN CSNK1G2 LOXL2 CGN ARHGAP29 LTBP1 ARHGAP20	2.33e-04	827	134	15	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	INHBA AFF3 MUC16 DAPK1 FRMD4B PTPN13 TENM4 RESF1 ZNF35 BRCA2 LOXL2 CGN ARHGAP29 LTBP1 ARHGAP20	2.45e-04	831	134	15	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NUSAP1 ZNF536 TRAF3 TNRC6B OCRL ANKHD1 PLEKHM1 LUZP1 CCDC66 LATS1 ALMS1 BRCA2 MKI67 ADGRA1 IFT80	2.45e-04	831	134	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	ABCA13 AFF3 SIRPB2 SIRPA ZFAND4 ZNF608 BRCA2 ANLN MKI67 MAML3	2.55e-04	405	134	10	GSM538343_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	TET2 COL6A3 INHBA MUC16 SNCAIP TENM4 LRFN5 LOXL2 ARHGAP20	2.88e-04	336	134	9	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	NUSAP1 ZNF536 MDM1 LUZP1 CCDC66 LATS1 HMCN2 ALMS1 BRCA2 MKI67 IFT80	2.93e-04	492	134	11	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6	GPR155 TRAF5 BMP2K AFF3 ARHGAP17 LAX1 ZNF608 PTPRJ DCLK2	3.08e-04	339	134	9	GSM403988_500
CoexpressionAtlas	alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3	NUSAP1 MDM1 FANCM ALMS1 BRCA2 ANLN MKI67 DCLK2 IFT80 PLK1	3.21e-04	417	134	10	GSM399403_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	COL6A3 AFF3 MUC16 DAPK1 FRMD4B PTPN13 TENM4 LOXL2 LTBP1 ARHGAP20	3.27e-04	418	134	10	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	COL6A3 MUC16 FRMD4B TENM4 LOXL2 LTBP1 ARHGAP20	3.49e-04	207	134	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500	INHBA AFF3 MUC16 DAPK1 FRMD4B TENM4 CGN ARHGAP29 LTBP1 ARHGAP20	3.59e-04	423	134	10	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	NUSAP1 EHBP1 TET2 ZNF536 ANK2 INHBA ASAH2 CHD9 PALMD RSC1A1 CCDC66 SNCAIP TENM4 DST L3MBTL1 NGFR LTBP1 ARHGAP20	3.92e-04	1166	134	18	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	NRIP1 INHBA AFF3 DIDO1 CHD9 OCRL FRMD4B TENM4 RESF1 ADGRG2 ATXN1 LOXL2 CPEB4 ARHGAP20	4.78e-04	790	134	14	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	NRIP1 DIDO1 CHD9 OCRL FRMD4B FOCAD TENM4 RESF1 MEIOC ADGRG2 LOXL2 CGN CPEB4 ARHGAP29	5.09e-04	795	134	14	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	COL6A3 INHBA PTPRJ CGN ARHGAP20	5.18e-04	104	134	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	NRIP1 INHBA AFF3 DIDO1 CHD9 OCRL FRMD4B LUZP1 TENM4 RESF1 ADGRG2 LOXL2 CPEB4 ARHGAP20	5.48e-04	801	134	14	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_100	INHBA ADGRG2 ARHGAP20	5.74e-04	26	134	3	gudmap_developingGonad_e18.5_epididymis_100_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	TTF2 NRIP1 DIDO1 CHD9 OCRL ANKHD1 FRMD4B TENM4 RESF1 UBAP2L LOXL2 CPEB4 ARHGAP20 PLK1	5.82e-04	806	134	14	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	B cells, B.FrE.FL, AA4.1+ IgM+ CD19+ CD43- CD24+, Fetal Liver, avg-3	NUSAP1 GPR155 AFF3 ARHGAP17 ZNF608 PTPRJ ANLN MKI67 PLK1	6.02e-04	372	134	9	GSM538204_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	COL6A3 INHBA MUC16 DAPK1 PALMD FAH CGN ARHGAP29 ARHGAP20	6.02e-04	372	134	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	COL6A3 INHBA AFF3 MUC16 REV3L FRMD4B TENM4 LOXL2 ARHGAP20	6.14e-04	373	134	9	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	COL6A3 INHBA MUC16 TENM4 LOXL2 ARHGAP20	6.36e-04	165	134	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	NUSAP1 DIDO1 CHD9 ZFAND4 LUZP1 CCDC66 RNF2 BRCA2 ATXN1 UBAP2L MKI67 MAML3	6.47e-04	629	134	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	NRIP1 INHBA FRMD4B RESF1 ADGRG2 ARHGAP20	6.56e-04	166	134	6	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	AFF3 DAPK1 REV3L FAH PTPN13 RESF1 CGN	6.71e-04	231	134	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	NUSAP1 ZNF536 LUZP1 CCDC66 BRCA2 ATXN1 ADGRA1	6.89e-04	232	134	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	COL6A3 INHBA PALMD SNCAIP LOXL2 ARHGAP20	6.99e-04	168	134	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000
CoexpressionAtlas	gamma delta T cells, Tgd.vg1+vd6+.Th, TCRd+ Vd6.3+ Vg1.1+, Thymus, avg-1	NUSAP1 ZNF536 NTRK3 LAX1 PTPN13 MKI67 IFT80 PLK1	7.69e-04	308	134	8	GSM605775_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500	COL6A3 AFF3 MUC16 DAPK1 TENM4 CGN ARHGAP29 LTBP1 ARHGAP20	8.12e-04	388	134	9	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_100	INHBA ARHGAP20	8.13e-04	7	134	2	gudmap_developingGonad_e14.5_ epididymis_100_k4
CoexpressionAtlas	alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3	NUSAP1 GPR155 ZNF536 NTRK3 LAX1 ANLN MKI67 SMOX PLK1	8.73e-04	392	134	9	GSM538335_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	NUSAP1 FANCM LUZP1 CCDC66 BRCA2 ATXN1 CHD6	9.70e-04	246	134	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	NUSAP1 ZNF536 TRAF3 TRIM2 ANK2 ARHGAP17 CHD9 REV3L FANCM MYEF2 CCDC66 L3MBTL1 ALMS1 BRCA2 FKTN MKI67 ZBTB10 DCLK2 SOS2	9.87e-04	1370	134	19	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	NRIP1 INHBA AFF3 CHD9 FRMD4B RESF1 ADGRG2 LOXL2 ARHGAP20	1.08e-03	404	134	9	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	NRIP1 INHBA AFF3 CHD9 FRMD4B RESF1 ADGRG2 LOXL2 ARHGAP20	1.12e-03	406	134	9	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3	NUSAP1 IFT22 MDM1 MYEF2 ALMS1 BRCA2 ANLN MKI67 PLK1	1.17e-03	409	134	9	GSM399452_500
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3	NUSAP1 FANCM ZFAND4 PTPN13 BRCA2 ATXN1 ANLN MKI67 PLK1	1.19e-03	410	134	9	GSM538387_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_200	INHBA ADGRG2 ARHGAP20	1.27e-03	34	134	3	gudmap_developingGonad_e16.5_epididymis_200_k1
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	NRIP1 DIDO1 CHD9 OCRL FRMD4B TENM4 ARHGAP20	1.31e-03	259	134	7	gudmap_developingGonad_e12.5_epididymis_k3_1000
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	NUSAP1 DAPK1 SIRPB2 FRMD4B PTPRJ BRCA2 ANLN MKI67 MAML3	7.65e-09	192	135	9	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	7.40e-08	178	135	8	15a99080e9f669572ab6d82934f324e6714846c1
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	7.40e-08	178	135	8	200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCell	5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NUSAP1 PALMD ANLN MKI67 FBXO43 ARHGAP29 ARHGEF3 PLK1	7.40e-08	178	135	8	ea10117026021c959ffc871fc377cdb3e161d264
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	8.42e-08	181	135	8	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	8.42e-08	181	135	8	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	8.79e-08	182	135	8	9025178ede571e3808d4657ad4892152f336c9b4
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 ANLN KLF5 MKI67 PLK1	8.79e-08	182	135	8	c075756cd4bb484ede1be2bcdb9eac60eab0573a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 COL6A3 INHBA BRCA2 ANLN LRFN5 MKI67 FBXO43	1.08e-07	187	135	8	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 COL6A3 INHBA BRCA2 ANLN LRFN5 MKI67 FBXO43	1.08e-07	187	135	8	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	(04)_Pre-ciliated\|World / shred by cell type and Timepoint	TRAF5 IFT22 MDM1 ZFAND4 ALMS1 KLF5 FBXO43 PCNT	1.27e-07	191	135	8	37cf121e6e80760c8519075b7845b9029958a988
ToppCell	RV-08._Macrophage\|RV / Chamber and Cluster_Paper	NUSAP1 DAPK1 SIRPB2 FRMD4B PTPRJ BRCA2 ANLN MKI67	1.38e-07	193	135	8	12bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22\|World / Primary Cells by Cluster	ANK2 INHBA PALMD FRMD4B TENM4 ZNF608 ADGRG2 AKAP13	1.38e-07	193	135	8	3b927d4b8ecb21a408424ef91a23746c21741f49
ToppCell	PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NUSAP1 EXPH5 MYEF2 ANLN CGN MKI67 FBXO43 PLK1	1.43e-07	194	135	8	c197e4acbff42a9f0410b6801c2bfcf6160aefc1
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	CHD9 PALMD ZNF804A FRMD4B SNCAIP TENM4 ZNF608 BTF3	1.55e-07	196	135	8	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	CHD9 PALMD ZNF804A FRMD4B SNCAIP TENM4 ZNF608 BTF3	1.55e-07	196	135	8	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	TRIM2 ABCA13 EXPH5 CDHR3 MUC16 CFAP43 KLF5 CGN	1.61e-07	197	135	8	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	severe-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NUSAP1 INHBA ABCA13 ABHD5 BRCA2 ANLN KLF5 MKI67	1.81e-07	200	135	8	5ee43386da8261d2e7602a152e6ba4338d844e08
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TRIM2 ABCA13 EXPH5 MUC16 PTPN13 DST KLF5 CGN	1.81e-07	200	135	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Control-Fibroblasts-Mesothelial_FB\|Control / group, cell type (main and fine annotations)	ANK2 TENM4 ADGRG2 LRFN5 LOXL2 NGFR LTBP1	2.30e-07	139	135	7	e769beb031b262dd92c9605b07dbf3c29fb82520
ToppCell	COVID-19_Mild-Neu_0\|World / 5 Neutrophil clusters in COVID-19 patients	TRIM2 ANK2 ZNF215 PALMD STN1 TENM4 ADGRG2	2.41e-07	140	135	7	93f024473b1bb3bf93ae776fd6a8fc5e93d013f0
ToppCell	10x5'-Liver-Hematopoietic_progenitors\|Liver / Manually curated celltypes from each tissue	NUSAP1 INHBA FANCM BRCA2 ANLN MKI67 PLK1	7.63e-07	166	135	7	ae967570248cf86ca3ddf55e33bcbb3e4e3684bc
ToppCell	10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Liver / Manually curated celltypes from each tissue	NUSAP1 INHBA FANCM BRCA2 ANLN MKI67 PLK1	7.63e-07	166	135	7	a176e87aa6eec81d1fb79a028f759182d11b567d
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EHBP1 GPR155 ZNF536 ANK2 CADM4 DST NGFR	8.27e-07	168	135	7	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 INHBA ABCA13 ABHD5 KLF5 MKI67 PLK1	9.32e-07	171	135	7	913bae728b5e653771a27c79a309eb023699f1d0
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF536 INHBA ABCA13 ABHD5 KLF5 MKI67 PLK1	9.32e-07	171	135	7	f28b2336057e353b96a6ff4581ec9fd0ca0789d9
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 KLF5 MKI67 PLK1	9.32e-07	171	135	7	95e87987a2332fa646849fb0de785f1e0b8a07dd
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 KLF5 MKI67 PLK1	9.32e-07	171	135	7	36657e277aad75c4f157c1726c48e09b5836cf37
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	NUSAP1 TTF2 ANK2 ANLN MKI67 FBXO43 PLK1	9.32e-07	171	135	7	0eea035fde32cc2a75a0d4227911edb5d54ed47e
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	EHBP1 GPR155 ZNF536 ANK2 CADM4 PTPN13 PTPRJ	1.01e-06	173	135	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	1.52e-06	184	135	7	a8c6028d745aaa6ee7842259238694cb50ce0526
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	1.52e-06	184	135	7	081d045f3bc98a36f342de7d50f39c9a888dd7eb
ToppCell	Control-Myeloid_G-immature_Neutrophil\|Control / Disease group, lineage and cell class	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	1.52e-06	184	135	7	45f873236f7e90fb78c8e291d3b5b92d121acec9
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	1.52e-06	184	135	7	84c20730cd92b9aaa50077d7b625e37e7f9e91d2
ToppCell	PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	1.52e-06	184	135	7	d31d4116d1d196633784863781fa45673607a421
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ANK2 PALMD DST CPEB4 PDE4DIP AKAP13 LTBP1	1.52e-06	184	135	7	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ZNF536 ANK2 AFF3 FOCAD TENM4 DST LOXL2	1.63e-06	186	135	7	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NUSAP1 TTF2 BRCA2 ANLN MKI67 FBXO43 HSPA6	1.95e-06	191	135	7	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DAPK1 ANKHD1 PTPRJ ATXN1 PCNX1 AKAP13 MAML3	2.09e-06	193	135	7	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4\|World / Primary Cells by Cluster	ZNF536 CHD9 DST ZNF608 PDE4DIP DCLK2 CHD6	2.09e-06	193	135	7	2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NUSAP1 INHBA ABCA13 BRCA2 ANLN KLF5 MKI67	2.09e-06	193	135	7	ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	COL6A3 ANK2 TENM4 DST LRFN5 LTBP1 DCLK2	2.16e-06	194	135	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NUSAP1 INHBA ABHD5 BRCA2 ANLN MKI67 PLK1	2.16e-06	194	135	7	e5b81a8e52259a54a911c1c2ac932c98c988318d
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NUSAP1 INHBA ABCA13 BRCA2 ANLN KLF5 MKI67	2.16e-06	194	135	7	23318a1b55895b5166c6151f488a94a09b4627ff
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TMCO5A CDHR3 MUC16 CFAP43 ANLN FBXO43 PLK1	2.24e-06	195	135	7	e525b69145059b66417589601f7109af63730f3a
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 BMP2K INSL5 CHD9 USP8 DST MAML3	2.24e-06	195	135	7	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	NUSAP1 TTF2 BRCA2 ANLN MKI67 PLK1 PCNT	2.24e-06	195	135	7	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 INHBA NTRK3 AFF3 ZNF804A HMCN2 LTBP1	2.31e-06	196	135	7	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	NUSAP1 COL6A3 BRCA2 ANLN MKI67 FBXO43 PLK1	2.31e-06	196	135	7	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 INHBA NTRK3 AFF3 ZNF804A HMCN2 LTBP1	2.31e-06	196	135	7	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NUSAP1 COL6A3 BRCA2 ANLN MKI67 FBXO43 PLK1	2.31e-06	196	135	7	ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 ANK2 REV3L DST LRFN5 LTBP1 ARHGAP20	2.39e-06	197	135	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRAF3 BMP2K DAPK1 SIRPB2 ZNF804A PTPRJ HSPA6	2.39e-06	197	135	7	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 CADM4 MYEF2 DST MKI67 NGFR PLK1	2.39e-06	197	135	7	cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 AFF3 DAPK1 FRMD4B DST LRFN5 ARHGAP20	2.39e-06	197	135	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / Treatment groups by lineage, cell group, cell type	NUSAP1 PALMD ZNF608 BRCA2 ANLN MKI67 PLK1	2.39e-06	197	135	7	038fd92750257d43d5e980fd06d77742b543f11a
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-FOXM1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NUSAP1 TTF2 MYEF2 BRCA2 ANLN MKI67 PLK1	2.56e-06	199	135	7	98575fcce726589e93fbb4df1aab03e57cb56076
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NUSAP1 TTF2 BRCA2 ADGRG2 ANLN MKI67 PLK1	2.56e-06	199	135	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	COL6A3 INHBA REV3L DST LRFN5 LOXL2 LTBP1	2.56e-06	199	135	7	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PALMD LUZP1 DST RESF1 ZNF608 ARHGAP29 ARHGEF3	2.64e-06	200	135	7	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 ANK2 REV3L DST LTBP1 MINDY4 ARHGAP20	2.64e-06	200	135	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRIM2 ABCA13 EXPH5 MUC16 PTPN13 KLF5 CGN	2.64e-06	200	135	7	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil\|COVID-19_Severe / Disease, condition lineage and cell class	INHBA ABCA13 ABHD5 BRCA2 ANLN KLF5 MKI67	2.64e-06	200	135	7	cbe667eda1af222467df8bfa157aa22df488f133
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TRIM2 ABCA13 EXPH5 PTPN13 DST KLF5 CGN	2.64e-06	200	135	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	NUSAP1 TNFRSF10C ANLN MKI67 TRMT1L PLK1 PCNT	2.64e-06	200	135	7	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PALMD LUZP1 DST RESF1 ZNF608 ARHGAP29 ARHGEF3	2.64e-06	200	135	7	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PALMD REV3L DST ZNF608 ARHGAP29 DCLK2 ARHGEF3	2.64e-06	200	135	7	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL6A3 ANK2 REV3L DST LTBP1 MINDY4 ARHGAP20	2.64e-06	200	135	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	severe-immature_Neutrophil\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	INHBA ABCA13 ABHD5 BRCA2 ANLN KLF5 MKI67	2.64e-06	200	135	7	a9b87accdaa6956116ab82427e1330e8f007ef94
ToppCell	LPS_only-Endothelial-Endothelial-FOXM1\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NUSAP1 PALMD BRCA2 ANLN MKI67 PLK1	3.42e-06	134	135	6	4d8f7ddad02fe76a614771e115ebb8e04623ba85
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NUSAP1 MKI67 NGFR LTBP1 ARHGAP20 PLK1	5.18e-06	144	135	6	bdd6d00b2d1c9dad989df82367a60e8be79de816
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 MKI67 PLK1	7.61e-06	154	135	6	71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 MKI67 PLK1	7.61e-06	154	135	6	46155f36d3983f637b55d7525b675c8828f6ab2e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 ABHD5 ADGRG2 ANKRD30A NGFR ARHGAP20	9.82e-06	161	135	6	a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NUSAP1 TTF2 BRCA2 ANLN MKI67 PLK1	1.05e-05	163	135	6	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA ABCA13 ABHD5 MKI67 SEL1L2 PLK1	1.09e-05	164	135	6	2a230ea066decb798a0e6f2b96c7608c8e608031
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	NUSAP1 TTF2 ANLN MKI67 FBXO43 PLK1	1.09e-05	164	135	6	0662cd9d21608efacc336e0a582859f3b9a4951d
ToppCell	facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INHBA ABCA13 ABHD5 MKI67 SEL1L2 PLK1	1.09e-05	164	135	6	d02d39edd0bfef5a53b814ec6d5f026d41253218
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	CFAP43 RESF1 SMG7 ZNF608 UBAP2L MAML3	1.17e-05	166	135	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IFT22 INHBA ANLN ARHGAP29 SEL1L2 SOS2	1.17e-05	166	135	6	3b750d4023a0a09d86113aae5a97d84391f7b482
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 BRCA2 ANLN MKI67 FBXO43 PLK1	1.17e-05	166	135	6	2642544070564debe2deb2938d2c33997bf5ef02
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 RESF1 MKI67	1.21e-05	167	135	6	1bd27ffe381d26731b6d4cc5f29b27f1bac4473b
ToppCell	VE-Treg-exh_CD4\|VE / Condition, Cell_class and T cell subcluster	TRAF3 MDM1 OCRL RNF215 PTPN13 DMWD	1.21e-05	167	135	6	1036ac1ef9440612500137af9d1929672b077e4d
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	ANK2 NTRK3 TENM4 HMCN2 LTBP1 DCLK2	1.21e-05	167	135	6	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 PTPN13 ANLN CGN MKI67 PLK1	1.21e-05	167	135	6	a90f905ef38437752e2b0b71bd0322a184de1861
ToppCell	Control-B_cells-Activated_B_cells\|Control / group, cell type (main and fine annotations)	TRAF5 AFF3 TNRC6B ZNF804A RESF1 ZNF107	1.25e-05	168	135	6	a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NUSAP1 INHBA ABCA13 ABHD5 RESF1 MKI67	1.25e-05	168	135	6	faaba5ac01c2ebe380f56559374a121979a85a13
ToppCell	Dividing_Macrophages-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 BRCA2 ANLN MKI67 FBXO43 PLK1	1.29e-05	169	135	6	eb0c993ef2eea73bc4881182520922ce9ae9368f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 BRCA2 ANLN MKI67 FBXO43 PLK1	1.29e-05	169	135	6	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NUSAP1 TTF2 BRCA2 ANLN MKI67 PLK1	1.29e-05	169	135	6	e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCell	Control-T/NK_proliferative\|World / Disease group and Cell class	NUSAP1 INHBA MYEF2 ANLN MKI67 PLK1	1.29e-05	169	135	6	fca735cbb55fce4d32dc6632a39acea1d16b87ab
ToppCell	LV-16._Neuronal\|LV / Chamber and Cluster_Paper	EHBP1 GPR155 ZNF536 PTPN13 PTPRJ NGFR	1.29e-05	169	135	6	a8fc8ab0f0757e939e213efb61c03cfe390bf7d2
ToppCell	Dividing_Macrophages-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NUSAP1 INHBA BRCA2 ANLN MKI67 PLK1	1.29e-05	169	135	6	bc859a103cad567caf50c3c3882d2d2017807c73
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NUSAP1 TTF2 SIRPA ANLN MKI67 GNS	1.38e-05	171	135	6	845f312f8cbe29d820da25f0e6d75deb382bbfd8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 COL6A3 BRCA2 ANLN MKI67 FBXO43	1.38e-05	171	135	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NUSAP1 COL6A3 BRCA2 ANLN MKI67 FBXO43	1.38e-05	171	135	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 BMP2K DST RESF1 PTPRJ AKAP13	1.48e-05	173	135	6	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 BMP2K DST RESF1 PTPRJ AKAP13	1.48e-05	173	135	6	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 BMP2K DST RESF1 PTPRJ AKAP13	1.48e-05	173	135	6	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	BAL-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NUSAP1 MYEF2 ANLN MKI67 FBXO43 PLK1	1.53e-05	174	135	6	94575a605c725de83f66a6cf7df9d7bb360ffc56
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	EHBP1 NRIP1 EXPH5 L3MBTL1 SMG7 PDE4DIP AKAP13 LTBP1 SOS2	1.90e-06	191	133	9	6644_DN
Drug	Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	TRAF3 IFT22 INHBA EXPH5 PALMD ZNF804A ALMS1 AKAP13 TRMT1L	2.66e-06	199	133	9	7128_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	EHBP1 NRIP1 CHD9 REV3L TENM4 ATXN1 AKAP13 SOS2	7.59e-06	171	133	8	7535_DN
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	EHBP1 TRIM2 SNX19 TOX4 SMG7 ALMS1 PDE4DIP AKAP13	1.70e-05	191	133	8	4811_DN
Drug	0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A	TRAF3 INHBA TNRC6B L3MBTL1 RNF2 ALMS1 UBAP2L DMWD	1.83e-05	193	133	8	7057_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	NUSAP1 EHBP1 TRIM2 ALMS1 PCNX1 AKAP13 GNS SOS2	1.90e-05	194	133	8	4312_DN
Drug	Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; PC3; HT_HG-U133A	IFT22 CHD9 ZNF215 PALMD L3MBTL1 SMG7 ALMS1 ZNF107	2.04e-05	196	133	8	6692_DN
Drug	CAY10397; Down 200; 10uM; PC3; HT_HG-U133A	EHBP1 TRIM2 REV3L TFCP2 SMG7 BRCA2 CSNK1G2 GNS	2.04e-05	196	133	8	7087_DN
Drug	fludrocortisone acetate; Up 200; 1uM; MCF7; HG-U133A	TRAF3 SMG7 ADGRG2 PCNX1 LTBP1 DMWD MAML3 SOS2	2.12e-05	197	133	8	282_UP
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; PC3; HT_HG-U133A	TRAF3 TRIM2 BMP2K SIRPA BRCA2 ADGRG2 PDE4DIP ZNF107	2.12e-05	197	133	8	2126_DN
Drug	torcetrapib	EHBP1 TRIM2 INHBA CHD9 FANCM DST NFE2L2 CPEB4 ARHGAP29 ASAH2B	3.38e-05	342	133	10	ctd:C483909
Disease	liver cirrhosis (implicated_via_orthology)	FOCAD FAH NFE2L2	2.31e-05	13	130	3	DOID:5082 (implicated_via_orthology)
Disease	gastroesophageal reflux disease	NRIP1 AFF3 ABHD5 ADGRA1 MAML3	8.67e-05	101	130	5	EFO_0003948
Disease	intraocular pressure measurement	TTF2 COL6A3 TMCO5A AFF3 PTPRJ KLF5 AKAP13 LTBP1 ARHGAP20 SOS2	8.98e-05	509	130	10	EFO_0004695
Disease	ubiquitin carboxyl-terminal hydrolase 8 measurement	USP8 ARHGEF3	1.15e-04	4	130	2	EFO_0802179
Disease	KDEL motif-containing protein 2 measurement	EXPH5 ARHGEF3	1.15e-04	4	130	2	EFO_0801740
Disease	Epidermolysis Bullosa Simplex	EXPH5 DST	1.91e-04	5	130	2	C0079298
Disease	MYELODYSPLASTIC SYNDROME	TET2 DAPK1 FANCM BRCA2	2.22e-04	67	130	4	C3463824
Disease	systemic lupus erythematosus	COL6A3 TRAF3 ZFP90 AFF3 CHD9 ZNF804A PLEKHM1 STN1 TOX4 SMG7 ATXN1 SMOX	2.23e-04	799	130	12	MONDO_0007915
Disease	Sarcomatoid Renal Cell Carcinoma	TET2 ZNF536 DAPK1 ZNF804A AKAP13	2.64e-04	128	130	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TET2 ZNF536 DAPK1 ZNF804A AKAP13	2.64e-04	128	130	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TET2 ZNF536 DAPK1 ZNF804A AKAP13	2.64e-04	128	130	5	C1266044
Disease	Papillary Renal Cell Carcinoma	TET2 ZNF536 DAPK1 ZNF804A AKAP13	2.64e-04	128	130	5	C1306837
Disease	Renal Cell Carcinoma	TET2 ZNF536 DAPK1 ZNF804A AKAP13	2.64e-04	128	130	5	C0007134
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD6	3.99e-04	7	130	2	DOID:0050834 (implicated_via_orthology)
Disease	epidermolysis bullosa simplex (is_implicated_in)	EXPH5 DST	3.99e-04	7	130	2	DOID:4644 (is_implicated_in)
Disease	pulse pressure measurement	TET2 NRIP1 COL6A3 ANK2 INHBA TNRC6B SNX19 LUZP1 RNF215 TENM4 ATXN1 NFE2L2 AKAP13 LTBP1 IFT80 SOS2	4.22e-04	1392	130	16	EFO_0005763
Disease	central corneal thickness	TET2 COL6A3 AFF3 ATXN1 LOXL2 AKAP13 LTBP1	4.55e-04	309	130	7	EFO_0005213
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TET2 ZNF536 DAPK1 ZNF804A AKAP13	5.13e-04	148	130	5	C0279702
Disease	cognitive function measurement	ZNF536 TMCO5A INSL5 NTRK3 AFF3 SIRPA ZNF804A PLEKHM1 CCDC66 TENM4 ALMS1 ZNF608 ATXN1 CPEB4 LTBP1 MAML3	5.83e-04	1434	130	16	EFO_0008354
Disease	risk-taking behaviour	EHBP1 TET2 ZNF536 NTRK3 REV3L ABHD5 TENM4 ZNF608 LRFN5 CPEB4 ZBTB10	5.83e-04	764	130	11	EFO_0008579
Disease	mean platelet volume	TET2 MAN1C1 AFF3 CHD9 SIRPA FAH TOX4 PTPRJ MEIOC CPEB4 ZBTB10 LTBP1 ARHGEF3	5.85e-04	1020	130	13	EFO_0004584
Disease	signal-regulatory protein beta-1 measurement	SIRPB2 SIRPA	6.80e-04	9	130	2	EFO_0802069
Disease	lymphocyte count	TET2 TTF2 NRIP1 TRAF3 EXPH5 TNRC6B LAX1 FOCAD TOX4 CCDC66 TENM4 ALMS1 PTPRJ ARHGEF3 SMOX HSPA6	7.27e-04	1464	130	16	EFO_0004587
Disease	diet measurement	TTF2 ZNF536 ZFP90 TMCO5A TNRC6B PLEKHM1 ABHD5 TENM4 DST ZNF608 ATXN1 CHD6 MAML3	7.58e-04	1049	130	13	EFO_0008111
Disease	Alzheimer disease, educational attainment	TET2 AFF3 SNX19 PLEKHM1 USP8 MAML3	8.13e-04	247	130	6	EFO_0011015, MONDO_0004975
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	EXPH5 TNRC6B	8.47e-04	10	130	2	EFO_1000650, HP_0000131
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TET2 TRAF3 NTRK3 AFF3 REV3L ABHD5 TENM4 ALMS1 UBAP2L CPEB4 MAML3	8.58e-04	801	130	11	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	schizophrenia, intelligence, self reported educational attainment	TET2 AFF3 ZNF804A SNX19 ATXN1 PCNX1 MAML3	8.84e-04	346	130	7	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	corneal resistance factor	TET2 COL6A3 AFF3 PTPN13 ATXN1 LOXL2 AKAP13 LTBP1	8.97e-04	451	130	8	EFO_0010067
Disease	chronic obstructive pulmonary disease	EHBP1 TET2 COL6A3 TMCO5A AFF3 STN1 TENM4 CPEB4 DMWD MAML3	9.66e-04	688	130	10	EFO_0000341
Disease	cytokine measurement	ANK2 INHBA ZNF804A FOCAD ABHD5 ATXN1 NFE2L2 MKI67	1.03e-03	461	130	8	EFO_0004873
Disease	N-acetylhistidine measurement	IFT22 ALMS1	1.03e-03	11	130	2	EFO_0800022
Disease	platelet crit	TET2 NRIP1 ZFP90 EXPH5 AFF3 SIRPA STN1 RNF215 MEIOC ARHGAP29 ISG20L2 ARHGEF3	1.05e-03	952	130	12	EFO_0007985
Disease	mean corpuscular hemoglobin concentration	WASHC2C BMP2K TNRC6B SIRPA FRMD4B STN1 FOCAD ATXN1 UBAP2L NFE2L2 CPEB4 AKAP13 SMOX	1.21e-03	1105	130	13	EFO_0004528
Disease	cortical thickness	EHBP1 ZNF536 IFT22 INHBA MDM1 TNRC6B FRMD4B PLEKHM1 STN1 LUZP1 SMG7 CPEB4 SOS2	1.30e-03	1113	130	13	EFO_0004840
Disease	MAP kinase-activated protein kinase 3 measurement	TOX4 ARHGEF3	1.46e-03	13	130	2	EFO_0008226
Disease	Myopia	NRIP1 FRMD4B ABHD5 SNCAIP LRFN5 FBXO43 AKAP13	1.63e-03	385	130	7	HP_0000545
Disease	mean arterial pressure	WASHC2C DAPK1 STN1 USP8 PTPRJ CPEB4 ZBTB10 ARHGEF3	1.70e-03	499	130	8	EFO_0006340
Disease	red blood cell density measurement	TET2 WASHC2C BMP2K AFF3 TNRC6B STN1 FOCAD DST CPEB4 AKAP13 ARHGEF3	1.81e-03	880	130	11	EFO_0007978
Disease	prostate carcinoma	EHBP1 TET2 NRIP1 COL6A3 ANK2 EXPH5 TNRC6B ZFAND4 STN1 ANLN MAML3	2.00e-03	891	130	11	EFO_0001663
Disease	post-traumatic stress disorder	AFF3 ZNF804A LRFN5 IFT80 ZMYM4	2.05e-03	202	130	5	EFO_0001358
Disease	colorectal cancer (is_implicated_in)	NTRK3 PTPN13 PTPRJ MKI67	2.05e-03	121	130	4	DOID:9256 (is_implicated_in)
Disease	aspartate aminotransferase measurement	OCRL PLEKHM1 STN1 USP8 HMCN2 PTPRJ ATXN1 ARHGAP29 AKAP13 IFT80 SOS2	2.24e-03	904	130	11	EFO_0004736
Disease	household income	TET2 TRAF5 AFF3 ATXN1 PCNX1 MAML3	2.34e-03	304	130	6	EFO_0009695
Disease	hypertension	COL6A3 STN1 USP8 PTPRJ ZBTB10 SOS2	2.45e-03	307	130	6	EFO_0000537
Disease	muscular dystrophy (is_implicated_in)	COL6A3 FKTN	2.51e-03	17	130	2	DOID:9884 (is_implicated_in)
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	HSPA6 HSPA7	2.51e-03	17	130	2	EFO_0021969
Disease	neutrophil count, eosinophil count	TET2 TNFRSF10C USP8 PTPRJ ATXN1	2.58e-03	213	130	5	EFO_0004833, EFO_0004842
Disease	osteoarthritis, hip, osteoarthritis, knee	USP8 PTPRJ LTBP1	2.61e-03	62	130	3	EFO_0004616, EFO_1000786
Disease	Tinnitus	EHBP1 TNRC6B PTPN13 ISG20L2	2.66e-03	130	130	4	HP_0000360
Disease	serum IgG measurement	TRAF3 AFF3	2.81e-03	18	130	2	EFO_0004565
Disease	Bone marrow hypocellularity	FANCM BRCA2	2.81e-03	18	130	2	C1855710
Disease	attention deficit hyperactivity disorder, schizophrenia	ZNF536 SIRPB2 ZNF804A	2.86e-03	64	130	3	EFO_0003888, MONDO_0005090
Disease	Malignant Glioma	NTRK3 BRCA2 PLK1	3.69e-03	70	130	3	C0555198
Disease	mixed gliomas	NTRK3 BRCA2 PLK1	3.69e-03	70	130	3	C0259783
Disease	ubiquitin carboxyl-terminal hydrolase 25 measurement	USP8 ARHGEF3	4.20e-03	22	130	2	EFO_0021881
Disease	juvenile idiopathic arthritis	ABCA13 AFF3 LTBP1	4.31e-03	74	130	3	EFO_0002609

Protein segments in the cluster

Peptide	Gene	Start	Entry
KEHTSQNNEGTPTQK	TMCO5A	201	Q8N6Q1
FPNKDSQLVSSGHNN	AFF3	331	P51826
SLSNYDVNQPNKHGT	DAPK1	366	P53355
NQGTVIHFNNPKVQA	BTF3	111	P20290
GFPKQNVHFVNDNTI	CFAP43	26	Q8NDM7
HSSVQSVNFVNDGQK	ERVK-9	491	Q9UKH3
VSFKNGSQSQTHSLQ	ARHGEF3	416	Q9NR81
FVGANPKNSVQNQTH	ASAH2B	61	P0C7U1
DKESTVPQNQHITNG	ADGRG2	131	Q8IZP9
PGQDTQQFHEKSISA	AKAP13	956	Q12802
PGASVLQNEHSFQAQ	ADGRA1	241	Q86SQ6
SVGVFNSHFTEEQNP	ALMS1	2746	Q8TCU4
KNHQNTNPEGTSAGT	ANKRD30A	266	Q9BXX3
NHTNSGFRQNSKIDP	ABCA13	1826	Q86UQ4
TQSVSAQGKAGPHQQ	FLG	2056	P20930
SLSQTPGHKAEQQQQ	ATXN1	186	P54253
HSSINQENGTANPIK	BMP2K	696	Q9NSY1
KGTQPTCHDFNQFTA	DMWD	161	Q09019
FQQQKHPQGSLDTGE	INHBA	176	P08476
PQSVSKQAVGHEENA	LRFN5	586	Q96NI6
FPQTHKEQVQQDFSG	ANK2	3741	Q01484
HTAKTPDATFQRQGQ	MUC16	3841	Q8WXI7
FGKSEHQNSSPTCQE	PALMD	376	Q9NP74
ESFHKQNGTGTPQVE	PTPRJ	66	Q12913
HFPQGLSQSVVDANT	MAML3	1001	Q96JK9
KNPLGTANQTINGHF	NTRK3	381	Q16288
SAFVQAHPSNGQRVN	LATS1	221	O95835
QSQSHKVVEPGNTAF	GPR155	556	Q7Z3F1
KTFGPASISHDNNNI	DST	2721	Q03001
AATSSGQVFHLDKQQ	HMCN2	186	Q8NDA2
VNHSFAKQNSVQEQP	ANLN	216	Q9NQW6
FVGANPKNSVQNQTH	ASAH2	676	Q9NR71
SDFKPQNHNEVQSTT	FANCM	1746	Q8IYD8
QPHSKNQALNSTNGE	CSNK1G2	356	P78368
SQIHNNGQSDFRPKN	LOXL2	601	Q9Y4K0
QHFNNALPKQNSTTT	DCLK2	671	Q8N568
HSGNAQVTQTKFLPN	DDX1	271	Q92499
NKNPHANEFTSQGDR	PCNX1	491	Q96RV3
SLFQDSQAVTHNKNG	L3MBTL1	291	Q9Y468
QDQVAAPFQLSNHTG	LTBP1	336	Q14766
KAFNQNHPESTAEFN	NFE2L2	326	Q16236
QNGDHNTKVLQTDPA	COMMD2	156	Q86X83
KETAPAFAANQVFHN	MDM1	201	Q8TC05
PQNSTQAHSENKCSG	ISG20L2	156	Q9H9L3
QQQAEKDVPSSNIGH	LAX1	306	Q8IWV1
NTSPQGVHNDVSKFN	NRIP1	516	P48552
EKPAQNEGAQNSATF	NRIP1	611	P48552
SQRHQNEFKNVSESP	EXPH5	1696	Q8NEV8
HNFSSTNPTQVNGSV	MKI67	61	P46013
SNPTEFQNHEKQESQ	NUSAP1	111	Q9BXS6
QSAQAQPFHQEEKES	PCNT	1076	O95613
AAKSQAALNPHNTVF	HSPA7	56	P48741
AQQAETGNSFQLPHK	INSL5	56	Q9Y5Q6
SPIQGNNFKDSITHD	FBXO43	251	Q4G163
NVNKHLNSSQPSGFG	ARHGAP29	481	Q52LW3
ASGQKDQGHSPQTSF	FRMD4B	906	Q9Y2L6
TTISNQNGSPFHQQG	CHD9	131	Q3L8U1
EVSNTHQNSYQPGRK	CEFIP	201	Q711Q0
SSPNKDQVQQFSGNS	FHAD1	631	B1AJZ9
LEFENPHVTSNNKGT	IFT22	41	Q9H7X7
EFSKNPHIVSFVGNQ	IFT80	556	Q9P2H3
DFNSNHNLTPSQKAE	BRCA2	1096	P51587
PTKDGQAQTLQNHSG	CHD6	1161	Q8TD26
VNNHFTFSPNAGSNV	CDHR3	611	Q6ZTQ4
FLSGFPTTHAQQQQA	COL6A3	16	P12111
PTTHAQQQQADVKNG	COL6A3	21	P12111
FGHKQVNVPNNVTSS	COL6A3	2851	P12111
SQSQLFSQSTHKQPE	CCDC66	376	A2RUB6
AQNQALPSGHSKQTQ	CADM4	201	Q8NFZ8
KNEQTPSRFHFQGQA	DIDO1	2001	Q9BTC0
NFEQVKNTSHGSTSQ	FKTN	86	O75072
AGNKHNTNTATPFCN	EHBP1	836	Q8NDI1
LQGFSTSHKEGVNQP	LUZP1	616	Q86V48
LTNQALQEFGQKHSP	FAM166B	201	A8MTA8
VFAPRNKNFNIHGTN	GNS	251	P15586
STPNHDNKQQSFFLA	MAN1C1	571	Q9NR34
QSNTGNKSAFPVRFH	CPEB4	11	Q17RY0
SKHQDVFNQPTLNSF	FAH	56	P16930
AAKSQAALNPHNTVF	HSPA6	56	P17066
PGNEQYEVAQQKASH	RSC1A1	171	Q92681
NASTHSNQEAGPSNK	RNF2	181	Q99496
ENGFSEKIHQSTNQT	FOCAD	31	Q5VW36
QNTSDGIKHGFQTDN	PTPN13	836	Q12923
SQDHSKNQPFDVNTS	ARHGAP20	811	Q9P2F6
QAQAAPSQGHKSFRV	PLEKHM1	506	Q9Y4G2
ENVNKHNFQAKPQSG	MEIOC	601	A2RUB1
QPVIHSASSDQVNFK	STN1	241	Q9H668
PQSQFSIHASSNVNK	TRMT1L	571	Q7Z2T5
AQANGVSHNITFESP	SOS2	741	Q07890
AEAEKQQPQHSSSSN	MYEF2	36	Q9P2K5
NQAHKSSGTNFQGLP	ARHGAP17	156	Q68EM7
GNSEVTPNVNQGKHN	RESF1	846	Q9HCM1
EGNAAVPQNNATAFK	SEL1L2	346	Q5TEA6
QPQNSENGALHVTKD	TAF1C	41	Q15572
NQVQAGKQSHIPYSQ	SMG7	706	Q92540
AAQFHQENKGSGPQA	RNF215	121	Q9Y6U7
AHPKEQGSNTAAENT	SIRPA	351	P78324
QNHAGEKPSQSAERQ	SNCAIP	486	Q9Y6H5
SSPTEKNNDTQKHQG	SPATA31D4	51	Q6ZUB0
KFQISNNGQVPCHFS	OCRL	586	Q01968
KNGSFLPNIQVFASH	TRAF5	301	O00463
HCNVQTPSGETAFKN	ABHD5	251	Q8WTS1
LHNFAVGVNTNPSKA	ANHX	151	E9PGG2
KHNNTSRLPNQNGTV	ANKHD1	1906	Q8IWZ3
YDNHVGTSKQPAQSQ	CGN	241	Q9P2M7
SGQKSFAANGIQAHP	DNTTIP2	21	Q5QJE6
SSPTEKNNDTQKHQG	SPATA31D3	51	P0C874
SHPKETAVQASNNDF	SIRPB2	211	Q5JXA9
EENFPGQASSQQVHS	ZNF35	26	P13682
EHGKVFNQSSNLTTQ	ZNF107	556	Q9UII5
FQGTNQQIKAHEASS	TRAF3	241	Q13114
SQTFKNDSGPALSNH	nan	196	Q6ZTK2
HGVNVSVNASATPFQ	UBAP2L	941	Q14157
HFGNTANNFTQDTPI	MINDY4	81	Q4G0A6
HPNENTLGKNSFNFS	REV3L	696	O60673
AQNANTTQDPLSNKH	REV3L	1541	O60673
QQQKHEDGDSNGTFF	TFCP2	411	Q12800
DQQPHTQTASGQALK	NGFR	316	P08138
HDKPVNAESQNSVGV	SMOX	156	Q9NWM0
QQTVAPQQQRHSFKG	TNFRSF10C	36	O14798
LHQDATQTGEKPNNS	ZNF211	201	Q13398
LHKGNGENQFVSQQP	TENM4	1186	Q6N022
NSFKNQKHPESIQGS	WASHC2C	911	Q9Y4E1
ERKVGNNSSHFLQPN	SNX19	346	Q92543
KAHITAESAQGQGPN	ZNF536	321	O15090
ASVQASAPQGNSHKE	ZNF608	86	Q9ULD9
KSEDSNNPTLHFGNN	ZNF215	446	Q9UL58
SNKESPNQNNTTHLD	ZBTB10	396	Q96DT7
QFAGPHFAAVNSNNE	TRIM2	621	Q9C040
QTKHFLGNLPSSNGN	ZFAND4	366	Q86XD8
QSSHYSQPDKQGQSS	RPTN	471	Q6XPR3
EQTTHPELFAGNKTQ	TET2	846	Q6N021
ESTNHEQQSPQSGKV	USP8	426	P40818
DTQAAIKGQNPNATF	TOX4	236	O94842
PDNAQEYSHGQQQKT	ZMYM4	276	Q5VZL5
QIHNTDGPKNGNTNS	TNRC6B	366	Q9UPQ9
NEKSNSQVPQQSHFT	TTF2	466	Q9UNY4
EQAFSQQAISHPGEK	ZFP90	481	Q8TF47
AAAAGTFKVLQPHQQ	ZNF804A	1116	Q7Z570
SNGSVQINFFQDHTK	PLK1	526	P53350
PQNNSAEGNSHKYDI	ZNF302	216	Q9NR11
HTSAVPQTAVKQFQG	KLF5	266	Q13887
PQNTPKEANQAHSGF	PDE4DIP	1681	Q5VU43